<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS One</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40408431</article-id><article-id pub-id-type="pmc">PMC12101671</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0324511</article-id><article-id pub-id-type="publisher-id">PONE-D-24-50922</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Germ Cells</subject><subj-group><subject>OVA</subject><subj-group><subject>Oocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Lipids</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject><subj-group><subject>Obesity</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Lipids</subject><subj-group><subject>Lipid Metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Metabolism</subject><subj-group><subject>Lipid Metabolism</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Developmental Biology</subject><subj-group><subject>Embryology</subject><subj-group><subject>Embryos</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Macromolecular Structure Analysis</subject><subj-group><subject>Lipid Analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Parameters</subject><subj-group><subject>Body Weight</subject><subj-group><subject>Body Mass Index</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Chromatographic Techniques</subject><subj-group><subject>Liquid Chromatography</subject><subj-group><subject>Liquid Chromatography-Mass Spectrometry</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Analytical Chemistry</subject><subj-group><subject>Mass Spectrometry</subject><subj-group><subject>Liquid Chromatography-Mass Spectrometry</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Spectrum Analysis Techniques</subject><subj-group><subject>Mass Spectrometry</subject><subj-group><subject>Liquid Chromatography-Mass Spectrometry</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Impact of obesity on follicular fluid lipid composition and IVF/ICSI outcomes in Korean women: A lipidomic study</article-title><alt-title alt-title-type="running-head">Obesity, follicular Fluid Lipids composition and IVF/ICSI Outcomes in Korean Women</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0738-4153</contrib-id><name><surname>Ko</surname><given-names>Yoo Ra</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn002" ref-type="author-notes">
<sup>&#x0262f;</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1753-2674</contrib-id><name><surname>Kim</surname><given-names>Min Kyoung</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn002" ref-type="author-notes">
<sup>&#x0262f;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Ji Won</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="currentaff001" ref-type="author-notes">
<sup>&#x000a4;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Han</surname><given-names>E. Jung</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Se Jeong</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Jae Kyun</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="currentaff001" ref-type="author-notes">
<sup>&#x000a4;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ahn</surname><given-names>So Yeon</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Minseo</given-names></name><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Oh</surname><given-names>Surim</given-names></name><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hwang</surname><given-names>Sohyun</given-names></name><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Donghyeon</given-names></name><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="aff004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2191-666X</contrib-id><name><surname>Lim</surname><given-names>Hyunjung Jade</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Lee</surname><given-names>Woo Sik</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="currentaff001" ref-type="author-notes">
<sup>&#x000a4;</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Obstetrics and Gynecology, Fertility Center of CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Republic of Korea</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department of Pathology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Life Science, CHA University, Seongnam, Republic of Korea</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Swelum</surname><given-names>Ayman A</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>King Saud University / Zagazig University, EGYPT</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="current-aff" id="currentaff001"><p>&#x000a4; Current address: Seoul Fertility Clinic, Seoul, Republic of Korea</p></fn><fn fn-type="other" id="fn002"><p>&#x0262f; These authors contributed equally to this work and are co-first authors.</p></fn><corresp id="cor001">* E-mail: <email>hlim@konkuk.ac.kr</email> (HJL); <email>wsleesfc@gmail.com</email> (WSL)</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>20</volume><issue>5</issue><elocation-id>e0324511</elocation-id><history><date date-type="received"><day>23</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>25</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 Ko et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Ko et al</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0324511.pdf"/><abstract><sec id="sec017"><title>Background</title><p>Obesity negatively affects reproduction and <italic toggle="yes">in vitro</italic> fertilization (IVF) outcomes. However, its effects on lipid metabolism during embryonic development remain unclear. We examined follicular fluid (FF) lipid composition and body mass index (BMI)-related embryological outcomes in Korean women undergoing IVF/intracytoplasmic sperm injection (ICSI).</p></sec><sec id="sec018"><title>Methods</title><p>This prospective cohort study included 68 Korean women with infertility without metabolic diseases who underwent IVF/ICSI. Patients were categorized according to the 2022 guidelines of the Korean Society for the Study of Obesity as follows: Group A (obese, BMI&#x02009;&#x02265;&#x02009;25&#x02009;kg/m<sup>2</sup>, n&#x02009;=&#x02009;28) and Group B (non-obese, BMI&#x02009;&#x0003c;&#x02009;25&#x02009;kg/m<sup>2</sup>, n&#x02009;=&#x02009;40). Liquid chromatography-tandem mass spectrometry (LC-MS) was used to analyze lipids in the FF. Principal component analysis (PCA) and correlation analyses were performed. Embryological outcomes according to the BMI were compared using the QUADE nonparametric analysis of covariance adjusted for age and anti-M&#x000fc;llerian hormone.</p></sec><sec id="sec019"><title>Results</title><p>LC-MS identified 159 of the 230 lipids in the FF samples. Diacylglycerol (DAG), triacylglycerol (TAG), and acylcarnitine (AC) levels were significantly higher in the obese group; whereas monoacylglycerol (MAG) and plasmenyl phosphatidylcholine levels were lower. PCA explained 38.9% of the variance between the groups. Significant inter-group differences were found in the DAG (adjusted <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05) and AC 16:1 (adjusted <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.0139) levels. BMI and TAG, DAG, and AC levels (adjusted <italic toggle="yes">p&#x02009;</italic>&#x0003c;&#x02009;0.05) were positively correlated. Obese group had fewer fertilized oocytes (5.07&#x02009;&#x000b1;&#x02009;4.16 vs. 6.65&#x02009;&#x000b1;&#x02009;4.61, <italic toggle="yes">p&#x02009;</italic>=&#x02009;0.043), cleavage-stage embryos (4.86&#x02009;&#x000b1;&#x02009;4.26 vs. 6.63&#x02009;&#x000b1;&#x02009;4.61, <italic toggle="yes">p&#x02009;</italic>=&#x02009;0.016), and morula-stage embryos (4.00&#x02009;&#x000b1;&#x02009;4.51 vs. 6.05&#x02009;&#x000b1;&#x02009;5.14, <italic toggle="yes">p&#x02009;</italic>=&#x02009;0.024).</p></sec><sec id="sec020"><title>Conclusions</title><p>Obesity alters FF lipid composition in women with infertility undergoing IVF/ICSI, potentially affecting early embryonic development. This study improves our understanding of its effects on the ovarian microenvironment and offers insights into targeted IVF interventions.</p></sec></abstract><funding-group><award-group id="award001"><funding-source>
<institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003710</institution-id><institution>Korea Health Industry Development Institute</institution></institution-wrap>
</funding-source><award-id>HI22C1465</award-id></award-group><funding-statement>This research was supported by a grant from the Korea Health Technology R&#x00026;D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (HI22C1465).&#x0201d; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="7"/><table-count count="5"/><page-count count="17"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>Data cannot be shared publicly due to privacy and confidentiality restrictions. Data are available from CHA Gangnam Medical Center (contact via Professor Jin-Kyeong Ha, a faculty member at CHA Gangnam Center, at <email>hjk6018@chamc.co.kr</email>) for researchers who meet the criteria for access to data.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>Data cannot be shared publicly due to privacy and confidentiality restrictions. Data are available from CHA Gangnam Medical Center (contact via Professor Jin-Kyeong Ha, a faculty member at CHA Gangnam Center, at <email>hjk6018@chamc.co.kr</email>) for researchers who meet the criteria for access to data.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>According to the Health Insurance Review and Assessment Service-National Health Insurance Service of South Korea, the prevalence of obesity among women aged &#x0003e;20 years will increase by 27.8% by 2021, continuing the decade-long rise. The number of women treated for infertility in Korea is expected to increase from 121,038 in 2018&#x02013;140,458 in 2022. A recent study revealed that female infertility in Korea was associated with obesity, with an odds ratio of 2.06 (95% confidence interval, 1.61&#x02013;2.64) compared to women with a normal body mass index (BMI) (18.5&#x02009;kg/m<sup>2</sup>&#x02009;&#x02264;&#x02009;BMI&#x02009;&#x0003c;&#x02009;25&#x02009;kg/m<sup>2</sup>) [<xref rid="pone.0324511.ref001" ref-type="bibr">1</xref>]. Since South Korea has the lowest total fertility rate (0.78) among the Organization for Economic Co-operation and Development countries, the rising prevalence of obesity among reproductive-aged women, along with increasing infertility rates, poses a significant social challenge.</p><p>In 2021, the American Society for Reproductive Medicine outlined the adverse effects of obesity on reproduction, including impaired ovulatory function, decreased responsiveness to ovarian stimulation, diminished oocyte quality, lower fertilization rates, increased miscarriage rates, and increased risks of maternal and fetal complications during pregnancy [<xref rid="pone.0324511.ref002" ref-type="bibr">2</xref>]. These findings align with those of other studies [<xref rid="pone.0324511.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0324511.ref003" ref-type="bibr">3</xref>&#x02013;<xref rid="pone.0324511.ref006" ref-type="bibr">6</xref>]. However, obesity has not been reported to significantly affect the clinical or embryological outcomes of <italic toggle="yes">in vitro</italic> fertilization (IVF) [<xref rid="pone.0324511.ref007" ref-type="bibr">7</xref>&#x02013;<xref rid="pone.0324511.ref008" ref-type="bibr">8</xref>].</p><p>Despite the numerous studies on infertility and obesity, the underlying mechanisms remain unclear. Yong et al. reported that obesity affects the hypothalamic-pituitary-ovarian axis, oocyte maturation, embryonic development, and all stages of fetal development, leading to decreased female reproduction [<xref rid="pone.0324511.ref009" ref-type="bibr">9</xref>]. Lipotoxicity is the primary mechanism underlying this impairment, which causes mitochondrial damage in oocytes, an increase in reactive oxygen species, and endoplasmic reticulum stress. These conditions ultimately disrupt hormone production, the formation of cumulus-oocyte complexes (COC), fertilization, and embryonic development [<xref rid="pone.0324511.ref010" ref-type="bibr">10</xref>&#x02013;<xref rid="pone.0324511.ref015" ref-type="bibr">15</xref>]. Furthermore, obesity causes chronic inflammation by increasing proinflammatory cytokine levels and gene activity [<xref rid="pone.0324511.ref016" ref-type="bibr">16</xref>&#x02013;<xref rid="pone.0324511.ref018" ref-type="bibr">18</xref>].</p><p>As the follicular fluid (FF) represents the immediate microenvironment of the COC, its analysis provides insights into the effects of obesity on IVF outcomes. Alterations in the FF components can reflect in the metabolic levels and influence oocyte development, maturation, and embryo quality [<xref rid="pone.0324511.ref019" ref-type="bibr">19</xref>&#x02013;<xref rid="pone.0324511.ref021" ref-type="bibr">21</xref>]. Lipid metabolism is essential for oocyte meiosis and folliculogenesis. It provides energy through &#x003b2;-oxidation in mitochondria and functions both as a mediator for cell signaling and as a structural component of cellular membranes and steroid synthesis [<xref rid="pone.0324511.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0324511.ref022" ref-type="bibr">22</xref>&#x02013;<xref rid="pone.0324511.ref024" ref-type="bibr">24</xref>]. Previous studies have revealed that alterations in FF lipid composition are associated with follicular growth and oocyte development, thereby affecting IVF outcomes [<xref rid="pone.0324511.ref025" ref-type="bibr">25</xref>&#x02013;<xref rid="pone.0324511.ref030" ref-type="bibr">30</xref>]. Some studies have also sought to identify lipid metabolites in the FF as predictive markers of ovarian stimulation and follicular development [<xref rid="pone.0324511.ref031" ref-type="bibr">31</xref>&#x02013;<xref rid="pone.0324511.ref032" ref-type="bibr">32</xref>].</p><p>However, few studies have investigated the composition of BMI-related lipid metabolites in the FF [<xref rid="pone.0324511.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0324511.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0324511.ref026" ref-type="bibr">26</xref>,<xref rid="pone.0324511.ref033" ref-type="bibr">33</xref>&#x02013;<xref rid="pone.0324511.ref035" ref-type="bibr">35</xref>]. Triacylglycerols (TAG) and free fatty acids (FA) have been the focus of most studies on lipid metabolites [<xref rid="pone.0324511.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0324511.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0324511.ref025" ref-type="bibr">25</xref>,<xref rid="pone.0324511.ref026" ref-type="bibr">26</xref>,<xref rid="pone.0324511.ref034" ref-type="bibr">34</xref>,<xref rid="pone.0324511.ref035" ref-type="bibr">35</xref>]. While one study revealed no significant change in FF metabolic composition according to BMI, many others have demonstrated a positive correlation between maternal BMI and TAG/FA accumulation, which impairs oocyte development [<xref rid="pone.0324511.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0324511.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0324511.ref025" ref-type="bibr">25</xref>,<xref rid="pone.0324511.ref031" ref-type="bibr">31</xref>]. Additionally, animal <italic toggle="yes">in vitro</italic> maturation studies using lipid supplementation indicate that lipid metabolism with TAG and FA deposition influences oocyte maturation and development [<xref rid="pone.0324511.ref036" ref-type="bibr">36</xref>&#x02013;<xref rid="pone.0324511.ref038" ref-type="bibr">38</xref>]. However, data on its effects on human oocyte maturation are limited.</p><p>Therefore, a comprehensive lipidomics profiling of the FF was conducted to identify changes in metabolites and their effects on oocyte development and embryological outcomes in Korean women with infertility and obesity, defined as a BMI&#x02009;&#x02265;&#x02009;25&#x02009;kg/m<sup>2</sup> by the Korean Society for the Study of Obesity (KSSO) [<xref rid="pone.0324511.ref039" ref-type="bibr">39</xref>].</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><sec id="sec003"><title>Patient selection and follicular fluid collection</title><p>This was a single-center prospective cohort study. A total of 68 women without metabolic diseases (such as hyperlipidemia, hypertension, and diabetes mellitus) who underwent IVF/intracytoplasmic sperm injection (ICSI)-embryo transfer between February 2023 and September 2023 were included. The duration of infertility was defined as the period from the initial attempt at conception to the confirmation of clinical pregnancy as reported by the patient through self-examination. Women were divided into two BMI groups according to the KSSO definition. Group A (n&#x02009;=&#x02009;28) was defined as the obese group with a BMI&#x02009;&#x02265;&#x02009;25&#x02009;kg/m<sup>2</sup>, whereas Group B (n&#x02009;=&#x02009;40) was defined as the non-obese group with a BMI&#x02009;&#x0003c;&#x02009;25&#x02009;kg/m<sup>2</sup>. Transvaginal ultrasound-guided aspiration was used to collect FF from the antral follicles &#x0003e;15&#x02009;mm during oocyte retrieval.</p><p>A stereomicroscope and glass Pasteur pipette were used to retrieve the COC. Following oocyte retrieval, the FF was examined macroscopically. Follicular aspirates exhibiting severe viscosity, lack of clarity, or contamination with endometriotic cysts or the flushing medium were discarded. Only the uncontaminated FF samples were included in the analysis. All samples were preserved at 4 &#x000b0;C and transported to the laboratory on melting ice. This study was approved by the Institutional Review Board of CHA Gangnam Medical Center (IRB approval number: 2022-09-002). Written informed consent was obtained from all the patients.</p></sec><sec id="sec004"><title>Controlled ovarian hyperstimulation (COH) protocol</title><p>All patients underwent COH with gonadotropin-releasing hormone (GnRH) agonists or antagonists for pituitary suppression. Stimulation was personalized based on age, ovarian reserve test results, and previous ovarian responses to gonadotropins during stimulation cycles. Ovulation was induced using 250&#x02013;500 &#x003bc;g of recombinant human chorionic gonadotropin (hCG) (Ovidrel&#x000ae;; Serono, Modugno, Italy) and 0.1&#x02013;0.2&#x02009;mg of GnRH agonist (Decapeptyl&#x000ae;; Ferring, Sweden) when at least three follicles with a diameter of at least 17&#x02009;mm or at least two follicles with a diameter of at least 18&#x02009;mm were observed in both groups. Oocytes were retrieved 34&#x02013;36&#x02009;h after hCG and GnRH agonist administration.</p></sec><sec id="sec005"><title>Assessment of embryological outcomes</title><p>Embryological outcomes were assessed as follows: Mature oocytes (metaphase II [MII] oocytes) were defined as those with the first polar body and were subsequently used for ICSI. The oocyte maturation rate was defined as the ratio of MII oocytes to the total number of oocytes retrieved. The presence of two pronuclei and a second polar body 16&#x02013;18&#x02009;h after insemination confirmed normal fertilization. The normal fertilization rate was calculated by dividing the number of normally fertilized oocytes by the total number of retrieved oocytes. Total cleavage (CL), morula (MO), and blastocyst (BL) embryo formation rates were determined by dividing the number of embryos at each stage by the number of normally fertilized oocytes. Usable embryos were defined as those available for fresh embryo transfer, pre-implantation genetic testing, or vitrification.</p></sec><sec id="sec006"><title>Reagents</title><p>The liquid chromatography-mass spectrometry (LC-MS) grade solvents (isopropanol, methanol, and water), ammonium acetate, butylated hydroxytoluene, chloroform, and methyl <italic toggle="yes">tert</italic>-butyl ether were procured from Sigma-Aldrich (St. Louis, MO, USA). The internal standards were procured from Avanti Polar Lipids (Alabaster, AL, USA) and Sigma-Aldrich (St. Louis, MO, USA) (<xref rid="pone.0324511.t001" ref-type="table">Table 1</xref>).</p><table-wrap position="float" id="pone.0324511.t001"><object-id pub-id-type="doi">10.1371/journal.pone.0324511.t001</object-id><label>Table 1</label><caption><title>Internal standards used for quantification.</title></caption><alternatives><graphic xlink:href="pone.0324511.t001" id="pone.0324511.t001g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">No.</th><th align="left" rowspan="1" colspan="1">Compound</th><th align="left" rowspan="1" colspan="1">Stock conc.<break/>(ng/mL)</th><th align="left" rowspan="1" colspan="1">Final conc.<break/>(ng/mL)</th><th align="left" rowspan="1" colspan="1">Q<sub>1</sub><italic toggle="yes">m/z</italic></th><th align="left" rowspan="1" colspan="1">Q<sub>3</sub><italic toggle="yes">m/z</italic></th><th align="left" rowspan="1" colspan="1">Dwell<break/>time</th><th align="left" rowspan="1" colspan="1">Collision<break/>energy</th><th align="left" rowspan="1" colspan="1">Company</th><th align="left" rowspan="1" colspan="1">Catalog No.</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">PC 33:1<italic toggle="yes">d</italic>7 (15:0/18:1)</td><td align="left" rowspan="1" colspan="1">15060</td><td align="left" rowspan="1" colspan="1">1506</td><td align="left" rowspan="1" colspan="1">753.6</td><td align="left" rowspan="1" colspan="1">184.1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">-30</td><td align="left" rowspan="1" colspan="1">Avanti</td><td align="left" rowspan="1" colspan="1">330707</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">LPC 18:1 <italic toggle="yes">d</italic>7</td><td align="left" rowspan="1" colspan="1">2380</td><td align="left" rowspan="1" colspan="1">238</td><td align="left" rowspan="1" colspan="1">529.4</td><td align="left" rowspan="1" colspan="1">184.1</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">-25</td><td align="left" rowspan="1" colspan="1">Avanti</td><td align="left" rowspan="1" colspan="1">330707</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">PE 33:1 <italic toggle="yes">d</italic>7 (15:0/18:1)</td><td align="left" rowspan="1" colspan="1">530</td><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">711.6</td><td align="left" rowspan="1" colspan="1">570.5</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">-20</td><td align="left" rowspan="1" colspan="1">Avanti</td><td align="left" rowspan="1" colspan="1">330707</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">LPE 18:1 <italic toggle="yes">d</italic>7</td><td align="left" rowspan="1" colspan="1">490</td><td align="left" rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">487.3</td><td align="left" rowspan="1" colspan="1">346.3</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">-25</td><td align="left" rowspan="1" colspan="1">Avanti</td><td align="left" rowspan="1" colspan="1">330707</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">CE 18:1 <italic toggle="yes">d</italic>7</td><td align="left" rowspan="1" colspan="1">32910</td><td align="left" rowspan="1" colspan="1">3291</td><td align="left" rowspan="1" colspan="1">675.7</td><td align="left" rowspan="1" colspan="1">369.3</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">-18</td><td align="left" rowspan="1" colspan="1">Avanti</td><td align="left" rowspan="1" colspan="1">330707</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">SM 36:2 <italic toggle="yes">d</italic>9 (d18:1/18:1)</td><td align="left" rowspan="1" colspan="1">2960</td><td align="left" rowspan="1" colspan="1">296</td><td align="left" rowspan="1" colspan="1">738.6</td><td align="left" rowspan="1" colspan="1">184.1</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">-32</td><td align="left" rowspan="1" colspan="1">Avanti</td><td align="left" rowspan="1" colspan="1">330707</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">MAG 18:1 <italic toggle="yes">d</italic>7</td><td align="left" rowspan="1" colspan="1">2000</td><td align="left" rowspan="1" colspan="1">200</td><td align="left" rowspan="1" colspan="1">381.3</td><td align="left" rowspan="1" colspan="1">346.3</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">-18</td><td align="left" rowspan="1" colspan="1">Avanti</td><td align="left" rowspan="1" colspan="1">330707</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">DAG 33:1 <italic toggle="yes">d</italic>7 (15:0/18:1)</td><td align="left" rowspan="1" colspan="1">880</td><td align="left" rowspan="1" colspan="1">88</td><td align="left" rowspan="1" colspan="1">605.6</td><td align="left" rowspan="1" colspan="1">570.5</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">-22</td><td align="left" rowspan="1" colspan="1">Avanti</td><td align="left" rowspan="1" colspan="1">330707</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">TAG 48:1 <italic toggle="yes">d</italic>7 (15:0/18:1 (<italic toggle="yes">d</italic>7)/15:0)</td><td align="left" rowspan="1" colspan="1">5280</td><td align="left" rowspan="1" colspan="1">528</td><td align="left" rowspan="1" colspan="1">829.8</td><td align="left" rowspan="1" colspan="1">570.5</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">-30</td><td align="left" rowspan="1" colspan="1">Avanti</td><td align="left" rowspan="1" colspan="1">330707</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">Ceramide 30:1 (d18:0/12:0)</td><td align="left" rowspan="1" colspan="1">1000</td><td align="left" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1">657.7</td><td align="left" rowspan="1" colspan="1">271.3</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">-25</td><td align="left" rowspan="1" colspan="1">Avanti</td><td align="left" rowspan="1" colspan="1">860678p</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">Acyl-carnitine 2:0 <italic toggle="yes">d3</italic></td><td align="left" rowspan="1" colspan="1">1000</td><td align="left" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1">207.2</td><td align="left" rowspan="1" colspan="1">85.1</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">-27</td><td align="left" rowspan="1" colspan="1">Avanti</td><td align="left" rowspan="1" colspan="1">330707</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">GalCer 30:1 (d18:1/12:0)</td><td align="left" rowspan="1" colspan="1">10000</td><td align="left" rowspan="1" colspan="1">1000</td><td align="left" rowspan="1" colspan="1">644.5</td><td align="left" rowspan="1" colspan="1">264.3</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">-35</td><td align="left" rowspan="1" colspan="1">Avanti</td><td align="left" rowspan="1" colspan="1">860544</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">Cholesterol <italic toggle="yes">d7</italic></td><td align="left" rowspan="1" colspan="1">30000</td><td align="left" rowspan="1" colspan="1">3000</td><td align="left" rowspan="1" colspan="1">376.4</td><td align="left" rowspan="1" colspan="1">147.3</td><td align="left" rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">-25</td><td align="left" rowspan="1" colspan="1">Avanti</td><td align="left" rowspan="1" colspan="1">791108</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>This table presents the details of the internal standards from Avanti SPLASH Lipid MIX. Internal standards, crucial for ensuring the reproducibility of the analyses, were prepared at a final concentration achieved through a 100-fold dilution, as described above.</p></fn><fn id="t001fn002"><p>Abbreviations: conc., concentration; PC, plasmenyl phosphatidylcholine; LPC, lysophosphatidylcholine; PE, phosphatidylethanolamine; LPE, lysophosphatidylethanolamine; CE, cholesteryl ester; SM, sphingomyelin; MAG, monoacylglycerol; DAG, diacylglycerol; TAG, triacylglycerol; GalCer, galactosylceramides.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec007"><title>Lipid extraction</title><p>The Matyash method (with minor modifications) was used for all lipid extractions [<xref rid="pone.0324511.ref040" ref-type="bibr">40</xref>]. In brief, methanol (300 &#x003bc;L) containing 0.1% butylated hydroxytoluene and methyl <italic toggle="yes">tert</italic>-butyl ether (1&#x02009;mL) was added to the FF (100 &#x003bc;L). After shaking for 1&#x02009;h at room temperature, 250 &#x003bc;L of water was added, and the mixture vortexed for 10&#x02009;min. Centrifugation was performed at 14,000&#x02009;&#x000d7;&#x02009;g (4 &#x000b0;C, 15&#x02009;min) for phase separation. The upper (220 &#x003bc;L) and lower (110 &#x003bc;L) phases were combined for analysis, and the solvent was evaporated. The sample was then reconstituted in 90 &#x003bc;L of methanol:chloroform (9:1, v/v) solvent with an internal standard mixture (10 &#x003bc;L) (<xref rid="pone.0324511.g001" ref-type="fig">Fig 1</xref>). This mixture contained PC 33:1-d7, LPC 18:1-d7, PE 33:1-d7, LPE 18:1-d7, CE 18:1-d7, SM 36:2-d9, MAG 18:1-d7, DAG 33:1-d7, TAG 48:1-d7, cholesterol-d7, ceramide 42:1-d7, AC 2:0-d3, and galactosylceramides 30:1.</p><fig position="float" id="pone.0324511.g001"><object-id pub-id-type="doi">10.1371/journal.pone.0324511.g001</object-id><label>Fig 1</label><caption><title>Lipid extraction procedure using the modified Matyash method. This schematic illustrates the process of lipid extraction from the follicular fluid (FF) using the Matyash method with minor modifications. The prepared samples were subjected to lipid analysis using liquified chromatography-mass spectrometry/mass spectrometry (LC-MS/MS).</title></caption><graphic xlink:href="pone.0324511.g001" position="float"/></fig></sec><sec id="sec008"><title>LC-MS analysis</title><p>LC-MS/MS (Shimadzu LCMS 8060 system, Shimadzu, Mass Spectrometry Based Convergence Research Institute, Kyungpook National University, Kyoto, Japan) was used to analyze all samples. Kinetex C18 column (100&#x02009;&#x000d7;&#x02009;2.1&#x02009;mm, 2.6 &#x003bc;m particle size, Phenomenex, Torrance, CA, USA) was used to separate them. Mobile phases A and B consisted of 10&#x02009;mM ammonium acetate in water/methanol (1:9, v/v) and 10&#x02009;mM ammonium acetate in methanol/isopropanol (1:1, v/v), respectively. The gradient elution conditions were: 30% B (0&#x02009;min), 95% B (15&#x02009;min), 95% B (20&#x02009;min), and 30% B (25&#x02009;min). The sample injection volume was 1 &#x003bc;L, and the flow rate was maintained at 0.2&#x02009;mL/min. The mass operating conditions were as follows: desolvation temperature, 250 &#x000b0;C; heat block temperature, 400 &#x000b0;C; spray voltage, 4&#x02009;kV; drying gas (nitrogen) flow rate, 10&#x02009;L/min; collision gas, argon; nebulizing gas (nitrogen) flow rate, 3&#x02009;L/min; collision gas pressure, 230 kPa; and detector voltage, 1.82&#x02009;kV. Selected reactions were monitored. Three samples were randomly selected from each group for the preliminary experiment, yielding 230 lipid species. These detected lipids were then analyzed. In the final analysis, 159 of 230 lipids (<xref rid="pone.0324511.t002" ref-type="table">Table 2</xref> and <xref rid="pone.0324511.s001" ref-type="supplementary-material">S1</xref>-<xref rid="pone.0324511.s005" ref-type="supplementary-material">S5 Tables</xref>) in the FF samples were quantified after validating the assay by confirming the presence of lipid species with a coefficient of variation &#x0003c;30% of the quality control (QC) sample.</p><table-wrap position="float" id="pone.0324511.t002"><object-id pub-id-type="doi">10.1371/journal.pone.0324511.t002</object-id><label>Table 2</label><caption><title>Selected reaction monitoring table.</title></caption><alternatives><graphic xlink:href="pone.0324511.t002" id="pone.0324511.t002g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Type</th><th align="left" colspan="2" rowspan="1">Number</th></tr></thead><tbody><tr><td align="left" rowspan="7" colspan="1">Phospholipid</td><td align="left" rowspan="1" colspan="1">Lysophosphatidylcholine</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="7" colspan="1">87</td></tr><tr><td align="left" rowspan="1" colspan="1">Lysophosphatidylethanolamine</td><td align="left" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">Phosphatidylcholine (PC)</td><td align="left" rowspan="1" colspan="1">24</td></tr><tr><td align="left" rowspan="1" colspan="1">Phosphatidylethanolamine (PE)</td><td align="left" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasmenyl PC</td><td align="left" rowspan="1" colspan="1">16</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasmanyl PC</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasmecyl PE</td><td align="left" rowspan="1" colspan="1">16</td></tr><tr><td align="left" rowspan="2" colspan="1">Sphingolipid</td><td align="left" rowspan="1" colspan="1">Sphingomyelin</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="2" colspan="1">11</td></tr><tr><td align="left" rowspan="1" colspan="1">Ceramide</td><td align="left" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="2" colspan="1">Sterol lipid</td><td align="left" rowspan="1" colspan="1">Cholesterol</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="2" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">Cholesteryl ester</td><td align="left" rowspan="1" colspan="1">9</td></tr><tr><td align="left" rowspan="1" colspan="1">Carnitine</td><td align="left" rowspan="1" colspan="1">Acylcarnitine</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">8</td></tr><tr><td align="left" rowspan="3" colspan="1">Neutral lipid</td><td align="left" rowspan="1" colspan="1">Monoacylglycerol</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="3" colspan="1">43</td></tr><tr><td align="left" rowspan="1" colspan="1">Diacylglycerol</td><td align="left" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">Triacylglycerol</td><td align="left" rowspan="1" colspan="1">37</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">159</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec009"><title>Statistical analysis</title><p>The data for all detected peaks, including the peak areas and retention times, were exported to an Excel file for lipidomic analysis. The QC samples were prepared by mixing equal amounts of lipid extracts from all samples. Lipidomics data were analyzed using the Student&#x02019;s t-test, Welch&#x02019;s t-test, or Wilcoxon rank-sum test based on the underlying assumptions of the parametric tests, including normality and equality of variance. The analyses were performed using the stats R package. Principal component analysis (PCA) was performed using the prcomp function in the stats R package. Correlation analyses were performed using the rcorr function in the HMISC R package. The p-values were adjusted for multiple comparisons using the Benjamini-Hochberg method with the p.adjust function from the stats R package. PCA and scatter plots were generated using the ggplot2 package in R.</p><p>Inter-group differences in clinical outcomes were assessed using the Student&#x02019;s t-test, Welch&#x02019;s t-test, or Wilcoxon rank-sum test for continuous variables, depending on the underlying assumptions of the parametric tests. Categorical variables are presented as percentages, and differences in these variables were analyzed using the Chi-squared test or Fisher&#x02019;s exact test. Due to unequal sample sizes, analysis of covariance or Quade&#x02019;s analysis of covariance was used to evaluate the differences between the BMI groups and embryological outcomes of IVF/ICSI, adjusting for potential confounders. Age and anti-M&#x000fc;llerian hormone (AMH) levels were selected as covariates based on clinical knowledge. P-values&#x02009;&#x0003c;&#x02009;0.05 were considered statistically significant. All analyses were performed using R software version 4.4.1.</p></sec></sec><sec sec-type="results" id="sec010"><title>Results</title><sec id="sec011"><title>Participant characteristics</title><p>The clinical characteristics of the 68 patients included in this study are presented in <xref rid="pone.0324511.t003" ref-type="table">Table 3</xref>. Group A (obese group, BMI&#x02009;&#x02265;&#x02009;25&#x02009;kg/m<sup>2</sup>) comprised 41.2% (n&#x02009;=&#x02009;28) of the participants, whereas Group B (non-obese group, BMI&#x02009;&#x0003c;&#x02009;25&#x02009;kg/m<sup>2</sup>) comprised 58.8% (n&#x02009;=&#x02009;40). The mean BMIs for the two groups were significantly different (Group A: 27.78&#x02009;&#x000b1;&#x02009;2.12&#x02009;kg/m<sup>2</sup>; Group B:22.00&#x02009;&#x000b1;&#x02009;2.37&#x02009;kg/m<sup>2</sup>; <italic toggle="yes">p&#x02009;</italic>&#x0003c;&#x02009;0.001). The mean total serum cholesterol levels were significantly different between groups (Group A: 213.78&#x02009;&#x000b1;&#x02009;36.64&#x02009;mg/dL; Group B: 195.24&#x02009;&#x000b1;&#x02009;0.78&#x02009;mg/dL; <italic toggle="yes">p&#x02009;</italic>=&#x02009;0.031). Additionally, the total cholesterol levels were positively correlated with the BMI (<italic toggle="yes">p&#x02009;</italic>=&#x02009;0.002); a unit-increase in BMI corresponded to an estimated increase of 3.601&#x02009;mg/dL in the serum cholesterol levels. Other variables, including age, cause of infertility, antral follicle count, basal follicle-stimulating hormone levels, AMH levels, infertility duration, and number of previous IVF attempts, were not significantly different between the groups. Other cycle variables, including stimulation protocol, total gonadotropin dose, duration of stimulation, estradiol level on the triggering day, type of trigger, and fertilization type, did not show significant differences between the groups (<xref rid="pone.0324511.t004" ref-type="table">Table 4</xref>).</p><table-wrap position="float" id="pone.0324511.t003"><object-id pub-id-type="doi">10.1371/journal.pone.0324511.t003</object-id><label>Table 3</label><caption><title>Clinical characteristics of patients categorized according to BMI.</title></caption><alternatives><graphic xlink:href="pone.0324511.t003" id="pone.0324511.t003g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">Group A<break/>(BMI&#x02009;&#x02265;&#x02009;25&#x02009;kg/m<sup>2</sup>)<break/>(n&#x02009;=&#x02009;28)</th><th align="left" rowspan="1" colspan="1">Group B<break/>(BMI&#x02009;&#x0003c;&#x02009;25&#x02009;kg/m<sup>2</sup>)<break/>(n&#x02009;=&#x02009;40)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Female age, years</td><td align="left" rowspan="1" colspan="1">37.82&#x02009;&#x000b1;&#x02009;4.14</td><td align="left" rowspan="1" colspan="1">38.13&#x02009;&#x000b1;&#x02009;3.33</td><td align="left" rowspan="1" colspan="1">0.739</td></tr><tr><td align="left" rowspan="1" colspan="1">Maternal BMI (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">27.78&#x02009;&#x000b1;&#x02009;2.12</td><td align="left" rowspan="1" colspan="1">22.00&#x02009;&#x000b1;&#x02009;2.37</td><td align="left" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Cause of infertility (n)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.088</td></tr><tr><td align="left" rowspan="1" colspan="1">Male factor</td><td align="left" rowspan="1" colspan="1">5 (17.9%)</td><td align="left" rowspan="1" colspan="1">9 (22.5%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Tubal factor</td><td align="left" rowspan="1" colspan="1">1 (3.6%)</td><td align="left" rowspan="1" colspan="1">1 (2.5%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ovulation disorder (e.g., PCOS)</td><td align="left" rowspan="1" colspan="1">5 (17.9%)</td><td align="left" rowspan="1" colspan="1">1 (2.5%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Endometriosis</td><td align="left" rowspan="1" colspan="1">1 (3.6%)</td><td align="left" rowspan="1" colspan="1">2 (5.0%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Uterine factor</td><td align="left" rowspan="1" colspan="1">1 (3.6%)</td><td align="left" rowspan="1" colspan="1">8 (20.0%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Diminished ovarian reserve</td><td align="left" rowspan="1" colspan="1">10 (35.7%)</td><td align="left" rowspan="1" colspan="1">8 (20.0%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unexplained</td><td align="left" rowspan="1" colspan="1">5 (17.9%)</td><td align="left" rowspan="1" colspan="1">11 (27.5%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Secondary infertility</td><td align="left" rowspan="1" colspan="1">1 (3.6%)</td><td align="left" rowspan="1" colspan="1">6 (15.0%)</td><td align="left" rowspan="1" colspan="1">0.226</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cholesterol level (mg/dL)</td><td align="left" rowspan="1" colspan="1">213.78&#x02009;&#x000b1;&#x02009;36.64</td><td align="left" rowspan="1" colspan="1">195.24&#x02009;&#x000b1;&#x02009;30.78</td><td align="left" rowspan="1" colspan="1">0.031</td></tr><tr><td align="left" rowspan="1" colspan="1">AFC count</td><td align="left" rowspan="1" colspan="1">13.07&#x02009;&#x000b1;&#x02009;8.21</td><td align="left" rowspan="1" colspan="1">11.48&#x02009;&#x000b1;&#x02009;6.16</td><td align="left" rowspan="1" colspan="1">0.689</td></tr><tr><td align="left" rowspan="1" colspan="1">Basal FSH level (mIU/mL)</td><td align="left" rowspan="1" colspan="1">7.79&#x02009;&#x000b1;&#x02009;2.65</td><td align="left" rowspan="1" colspan="1">8.14&#x02009;&#x000b1;&#x02009;3.51</td><td align="left" rowspan="1" colspan="1">0.980</td></tr><tr><td align="left" rowspan="1" colspan="1">AMH level (ng/mL)</td><td align="left" rowspan="1" colspan="1">2.91&#x02009;&#x000b1;&#x02009;3.05</td><td align="left" rowspan="1" colspan="1">2.09&#x02009;&#x000b1;&#x02009;1.54</td><td align="left" rowspan="1" colspan="1">0.737</td></tr><tr><td align="left" rowspan="1" colspan="1">Infertility duration (months)</td><td align="left" rowspan="1" colspan="1">37.54&#x02009;&#x000b1;&#x02009;24.67</td><td align="left" rowspan="1" colspan="1">29.33&#x02009;&#x000b1;&#x02009;24.38</td><td align="left" rowspan="1" colspan="1">0.050</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of previous IVF attempts (n)</td><td align="left" rowspan="1" colspan="1">2.14&#x02009;&#x000b1;&#x02009;2.76</td><td align="left" rowspan="1" colspan="1">1.78&#x02009;&#x000b1;&#x02009;2.14</td><td align="left" rowspan="1" colspan="1">0.802</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>BMI, body mass index; PCOS, polycystic ovary syndrome; AFC, antral follicle count; AMH, anti- M&#x000fc;llerian hormone; FSH, follicle-stimulating hormone; IVF, <italic toggle="yes">in vitro</italic> fertilization; n, number of cycles; NS, not significant (<italic toggle="yes">p</italic>&#x02009;&#x0003e;&#x02009;0.05). Values are presented as mean&#x02009;&#x000b1;&#x02009;standard deviation</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="pone.0324511.t004"><object-id pub-id-type="doi">10.1371/journal.pone.0324511.t004</object-id><label>Table 4</label><caption><title>Cycle characteristics of participants categorized according to BMI.</title></caption><alternatives><graphic xlink:href="pone.0324511.t004" id="pone.0324511.t004g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">Group A<break/>(BMI&#x02009;&#x02265;&#x02009;25&#x02009;kg/m<sup>2</sup>)<break/>(n&#x02009;=&#x02009;28)</th><th align="left" rowspan="1" colspan="1">Group B<break/>(BMI&#x02009;&#x0003c;&#x02009;25&#x02009;kg/m<sup>2</sup>)<break/>(n&#x02009;=&#x02009;40)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Stimulation protocol (n)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">GnRH long agonist</td><td align="left" rowspan="1" colspan="1">3 (10.7%)</td><td align="left" rowspan="1" colspan="1">5 (12.5%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">GnRH antagonist</td><td align="left" rowspan="1" colspan="1">25 (89.3%)</td><td align="left" rowspan="1" colspan="1">35 (87.5%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Total gonadotropin (IU)</td><td align="left" rowspan="1" colspan="1">2021.04&#x02009;&#x000b1;&#x02009;729.00</td><td align="left" rowspan="1" colspan="1">2212&#x02009;&#x000b1;&#x02009;817,60</td><td align="left" rowspan="1" colspan="1">0.326</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of simulation (days)</td><td align="left" rowspan="1" colspan="1">9.14&#x02009;&#x000b1;&#x02009;2.29</td><td align="left" rowspan="1" colspan="1">9.30&#x02009;&#x000b1;&#x02009;1.92</td><td align="left" rowspan="1" colspan="1">0.924</td></tr><tr><td align="left" rowspan="1" colspan="1">Estradiol on triggering day (pg/mL)</td><td align="left" rowspan="1" colspan="1">1387.00&#x02009;&#x000b1;&#x02009;1146.86</td><td align="left" rowspan="1" colspan="1">2124.06&#x02009;&#x000b1;&#x02009;1985.37</td><td align="left" rowspan="1" colspan="1">0.053</td></tr><tr><td align="left" rowspan="1" colspan="1">Trigger</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.778</td></tr><tr><td align="left" rowspan="1" colspan="1">Ovi</td><td align="left" rowspan="1" colspan="1">4 (14.3%)</td><td align="left" rowspan="1" colspan="1">8 (20.0%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ovi&#x02009;+&#x02009;Deca</td><td align="left" rowspan="1" colspan="1">22 (78.6%)</td><td align="left" rowspan="1" colspan="1">28 (70.0%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Deca</td><td align="left" rowspan="1" colspan="1">2 (7.1%)</td><td align="left" rowspan="1" colspan="1">4 (10.0%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Fertilization type (n)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">IVF</td><td align="left" rowspan="1" colspan="1">4 (14.3%)</td><td align="left" rowspan="1" colspan="1">5 (12.5%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ICSI</td><td align="left" rowspan="1" colspan="1">24 (85.7%)</td><td align="left" rowspan="1" colspan="1">35 (87.5%)</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>n, number of cycles; BMI, body mass index; GnRH, gonadotropin-releasing hormone; Ovi, oviderel; Deca, decapeptyl; IVF, <italic toggle="yes">in vitro</italic> fertilization; ICSI, intracytoplasmic sperm injection. Values are presented as mean&#x02009;&#x000b1;&#x02009;standard deviation or as number (%).</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec012"><title>Lipid composition analysis</title><p>A total of 159 of the 230 lipids (<xref rid="pone.0324511.t002" ref-type="table">Table 2</xref> and Additional File 1, <xref rid="pone.0324511.s001" ref-type="supplementary-material">S1&#x02013;</xref><xref rid="pone.0324511.s005" ref-type="supplementary-material">S5 Tables</xref>) in the FF samples were quantified. The assay was validated by confirming that lipid species with coefficient of variation &#x0003c;30% in the QC sample exceeded 70% (83.0%) of the total lipid species [<xref rid="pone.0324511.ref041" ref-type="bibr">41</xref>]. Significant differences were observed between the two groups in all neutral lipid compositions (<xref rid="pone.0324511.g002" ref-type="fig">Figs 2</xref> and <xref rid="pone.0324511.g003" ref-type="fig">3</xref>). Group A exhibited markedly higher concentrations of TAG than Group B (Group A: 132,443.3&#x02009;&#x000b1;&#x02009;71,011.6 pmol/mL; Group B: 92,298.1&#x02009;&#x000b1;&#x02009;41,084.8 pmol/mL; <italic toggle="yes">p&#x02009;</italic>=&#x02009;0.0102; <xref rid="pone.0324511.g002" ref-type="fig">Fig 2</xref>). Similarly, DAG levels were also elevated in Group A relative to Group B (Group A: 1,788.4&#x02009;&#x000b1;&#x02009;903.0 pmol/mL; Group B: 1,198.0&#x02009;&#x000b1;&#x02009;636.9 pmol/mL; <italic toggle="yes">p&#x02009;</italic>=&#x02009;0.0014; <xref rid="pone.0324511.g002" ref-type="fig">Fig 2</xref>). However, MAG levels (16:0) demonstrated a negative correlation with the BMI (Group A: 115,531.2&#x02009;&#x000b1;&#x02009;16,058.7 pmol/mL; Group B&#x02009;=&#x02009;126,500.0&#x02009;&#x000b1;&#x02009;17,281.2 pmol/mL; <italic toggle="yes">p&#x02009;=</italic>&#x02009;0.0149; <xref rid="pone.0324511.g003" ref-type="fig">Fig 3A</xref>).</p><fig position="float" id="pone.0324511.g002"><object-id pub-id-type="doi">10.1371/journal.pone.0324511.g002</object-id><label>Fig 2</label><caption><title>Lipid concentration differences (pmol/mL) between the BMI groups.</title><p>The bar graphs show the differences in lipid concentrations between the BMI groups. The lipid concentration (pmol/mL) was normalized to the volume. Different letters indicate significant differences compared with the control group [(*) <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, (**) <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01], as determined using the t-test. Data are shown as mean&#x02009;&#x000b1;&#x02009;standard deviation (n&#x02009;=&#x02009;28 and n&#x02009;=&#x02009;40). BMI, body mass index; LPC, Lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; PC, phosphatidylcholine; PE, phosphatidylethanolamine; MAG, monoacylglycerol; DAG, diacylglycerol; TAG, triacylglycerol; SM, sphingomyelin; CER, ceramide; CE, cholesteryl ester; AC, acylcarnitine; Group A, obese group; Group B, non-obese group.</p></caption><graphic xlink:href="pone.0324511.g002" position="float"/></fig><fig position="float" id="pone.0324511.g003"><object-id pub-id-type="doi">10.1371/journal.pone.0324511.g003</object-id><label>Fig 3</label><caption><title>Subgroup analysis of concentrations of neutral lipids (pmol/mL) which showed significant differences between BMI groups.</title><p>The bar graphs show the lipid subgroup concentration differences between the BMI groups and (A) MAG, (B) DAG, and (C) TAG. The lipid concentration (pmol/mL) was normalized to the volume. Different letters indicate significant differences compared with the control group [(*) <italic toggle="yes">p&#x02009;</italic>&#x0003c;&#x02009;0.05, (**) <italic toggle="yes">p&#x02009;</italic>&#x0003c;&#x02009;0.01], as determined by the t-test. The data shown as mean&#x02009;&#x000b1;&#x02009;standard deviation (n&#x02009;=&#x02009;28 and n&#x02009;=&#x02009;40). BMI, body mass index; MAG, monoacylglycerol; DAG, diacylglycerol; TAG, triacylglycerol.</p></caption><graphic xlink:href="pone.0324511.g003" position="float"/></fig><p>Additionally, a notable difference was observed in the composition of neutral lipids between groups. In Group A, the compositions of TAG and DAG were higher at 53.02% and 0.72%, respectively, compared to Group B, which had compositions of 41.19% and 0.54%, respectively. Conversely, Group A exhibited lower MAG content (46.26%) than Group B (57.27%).</p><p>Further analysis was conducted on the DAG lipid chains, covering five DAGs (32:2, 32:1, 34:0, 36:5, and 36:1), all showing statistical significance, with mean concentrations positively correlated with the groups (<xref rid="pone.0324511.g003" ref-type="fig">Fig 3B</xref>). Additionally, the analysis of 37 TAGs revealed significant differences in TAGs 48:0, 50:4, 50:3, 50:2, 50:1, 50:0, 52:5, 54:4, 52:3, 52:2, 52:1, 54:6, 54:5, 54:4, 54:3, 54:2, and 56:7 (<xref rid="pone.0324511.g003" ref-type="fig">Fig 3C</xref>).</p><p>Additionally, total AC levels were higher in group A than in group B (Group A: 4878.1&#x02009;&#x000b1;&#x02009;1179.3 pmol/mL; Group B: 4302.1&#x02009;&#x000b1;&#x02009;1216.0; <italic toggle="yes">p&#x02009;</italic>=&#x02009;0.0222; <xref rid="pone.0324511.g002" ref-type="fig">Fig 2</xref>). Chain analysis revealed significant differences in C2:0, C3:0, C16:0, C18:0, and C18:1 levels, all of which were higher in Group A than in Group B (<xref rid="pone.0324511.g004" ref-type="fig">Fig 4</xref>).</p><fig position="float" id="pone.0324511.g004"><object-id pub-id-type="doi">10.1371/journal.pone.0324511.g004</object-id><label>Fig 4</label><caption><title>Acylcarnitine subgroup concentration differences (pmol/mL) between BMI groups.</title><p>These bar graphs show the concentration differences between the BMI groups and the AC subgroup. The lipid concentration (pmol/mL) was normalized to the volume. Different letters indicate significant differences compared with the control group [(*) <italic toggle="yes">p&#x02009;</italic>&#x0003c;&#x02009;0.05, (**) <italic toggle="yes">p&#x02009;</italic>&#x0003c;&#x02009;0.01], as determined by the t-test. The data shown as mean&#x02009;&#x000b1;&#x02009;standard deviation (n&#x02009;=&#x02009;28 and n&#x02009;=&#x02009;40). BMI, body mass index; AC, acylcarnitine.</p></caption><graphic xlink:href="pone.0324511.g004" position="float"/></fig><p>Of the phospholipid family, only plasmenyl PC demonstrated a statistically significant inverse relationship with the BMI (Group A: 1,6093.3&#x02009;&#x000b1;&#x02009;5323.7 pmol/mL; Group B: 1,8121.9&#x02009;&#x000b1;&#x02009;4797.2 pmol/mL; <italic toggle="yes">p&#x02009;</italic>=&#x02009;0.0423; <xref rid="pone.0324511.g002" ref-type="fig">Fig 2</xref>). Further analysis of plasmenyl PC chains revealed that plasmenyl 34:0, 36:2, 40:7, and 40:4 showed significantly higher levels in Group B. No significant differences were observed between the groups in other lipids, such as sphingolipids (sphingomyelin and ceramide) or sterol lipids (cholesterol and cholesteryl ester) (<xref rid="pone.0324511.g002" ref-type="fig">Fig 2</xref>).</p><p>Adjusted <italic toggle="yes">p</italic>-value analysis revealed that, among the total lipids, only DAG showed a significant difference between groups. Among the total lipid chains, only AC 16:0 differed significantly between groups (adjusted p&#x02009;&#x0003c;&#x02009;0.05).</p><p>The lipid and lipid chain concentration data were not clearly separated between the obese and non-obese groups in the PCA (<xref rid="pone.0324511.g005" ref-type="fig">Figs 5A</xref> and <xref rid="pone.0324511.g005" ref-type="fig">5B</xref>). When analyzing only the lipids and lipid chains that showed a significant difference in abundance between the groups (<italic toggle="yes">p&#x02009;</italic>&#x0003c;&#x02009;0.05), some differences were observed. The variance explained by the first principal component increased significantly from 36.7% to 38.9% and from 26.8% to 41.0% for lipids and lipid chains, respectively, indicating that these discriminatory lipids or lipid chains could help distinguish between the groups (<xref rid="pone.0324511.g005" ref-type="fig">Figs 5C</xref> and <xref rid="pone.0324511.g005" ref-type="fig">5D</xref>).</p><fig position="float" id="pone.0324511.g005"><object-id pub-id-type="doi">10.1371/journal.pone.0324511.g005</object-id><label>Fig 5</label><caption><title>PCA plots for lipid and lipid chain concentrations.</title><p>The PCA plots show that the distributions of (A) all lipids, (B) all lipid chains, (C) lipids, and (D) lipid chains were significantly different between the two groups. The light green and red areas represent the 95% confidence intervals for each group. PCA, principal component analysis.</p></caption><graphic xlink:href="pone.0324511.g005" position="float"/></fig><p>Correlation analysis revealed a significant positive correlation between BMI and TAG, DAG, and AC levels (adjusted <italic toggle="yes">p&#x02009;</italic>&#x0003c;&#x02009;0.05; <xref rid="pone.0324511.g006" ref-type="fig">Fig 6</xref>). Further analysis of AC chains showed that AC 3:0, 16:0, 16:1, 18:0, and 18:1 levels were significantly positively associated with the BMI (adjusted <italic toggle="yes">p&#x02009;</italic>=&#x02009;0.014, 0.006, 0.019, 0.029, and 0.014, respectively; <xref rid="pone.0324511.g007" ref-type="fig">Fig 7</xref>).</p><fig position="float" id="pone.0324511.g006"><object-id pub-id-type="doi">10.1371/journal.pone.0324511.g006</object-id><label>Fig 6</label><caption><title>Correlation between lipid concentrations and BMI.</title><p>These scatter plots show a positive correlation between the BMI and (A) TAG, (B) DAG, and (C) AC levels, respectively. The red line represents the linear regression fit of each data point and the gray area indicates the 95% confidence interval of the regression fit. The correlation coefficient (r) was calculated using Spearman&#x02019;s correlation method. BMI, body mass index; TAG, triacylglycerol; DAG, diacylglycerol; AC, acylcarnitine.</p></caption><graphic xlink:href="pone.0324511.g006" position="float"/></fig><fig position="float" id="pone.0324511.g007"><object-id pub-id-type="doi">10.1371/journal.pone.0324511.g007</object-id><label>Fig 7</label><caption><title>Correlation between acylcarnitine subgroup concentrations and BMI.</title><p>Scatter plots show a positive correlation between the BMI and (A) AC 3:0, (B) AC 16:0, (C) AC 16:1, (D) AC 18:0, and (E) AC 18:1. The red line represents the linear regression fit of each data point and the gray area indicates the 95% confidence interval of the regression fit. The correlation coefficient (r) was calculated using Spearman&#x02019;s correlation method. BMI, body mass index; AC, acylcarnitine.</p></caption><graphic xlink:href="pone.0324511.g007" position="float"/></fig></sec><sec id="sec013"><title>Embryological outcomes</title><p>After adjusting for maternal age and AMH, which had the most significant impact on embryological outcomes, notable differences were observed in the numbers of fertilized oocytes, CL-stage embryos, and MO-stage embryos between Groups A and B. The total number of oocytes retrieved during the COH cycle was comparable between groups. However, in comparison to Group B, Group A had significantly fewer fertilized oocytes (Group A: 5.07&#x02009;&#x000b1;&#x02009;4.16; Group B: 6.65&#x02009;&#x000b1;&#x02009;4.61; <italic toggle="yes">p&#x02009;</italic>=&#x02009;0.043), as well as fewer CL-stage (Group A: 4.86&#x02009;&#x000b1;&#x02009;4.26; Group B: 6.63&#x02009;&#x000b1;&#x02009;4.61; <italic toggle="yes">p&#x02009;</italic>=&#x02009;0.016) and MO-stage (Group A: 4.00&#x02009;&#x000b1;&#x02009;4.51; Group B: 6.05&#x02009;&#x000b1;&#x02009;5.14; <italic toggle="yes">p&#x02009;</italic>=&#x02009;0.024) embryos. Nevertheless, Group A exhibited lower values across various embryological outcomes, including the number of mature oocytes retrieved, oocyte maturation rate, fertilization rate, CL-embryo formation rate, MO-embryo formation rate, number of total BL-stage embryos, BL formation rate, number of usable embryos, and usable embryo rate; however, these differences were not statistically significant (<xref rid="pone.0324511.t005" ref-type="table">Table 5</xref>).</p><table-wrap position="float" id="pone.0324511.t005"><object-id pub-id-type="doi">10.1371/journal.pone.0324511.t005</object-id><label>Table 5</label><caption><title>Comparison of IVF/embryological outcomes and clinical outcomes according to BMI groups with adjustment for age and AMH.</title></caption><alternatives><graphic xlink:href="pone.0324511.t005" id="pone.0324511.t005g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">Group A<break/>(BMI&#x02009;&#x02265;&#x02009;25&#x02009;kg/m<sup>2</sup>)<break/>(n&#x02009;=&#x02009;28)</th><th align="left" rowspan="1" colspan="1">Group B<break/>(BMI&#x02009;&#x0003c;&#x02009;25&#x02009;kg/m<sup>2</sup>)<break/>(n&#x02009;=&#x02009;40)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Oocytes retrieved<break/>in stimulated cycles (n)</td><td align="left" rowspan="1" colspan="1">10.50&#x02009;&#x000b1;&#x02009;8.86</td><td align="left" rowspan="1" colspan="1">10.50&#x02009;&#x000b1;&#x02009;6.58</td><td align="left" rowspan="1" colspan="1">0.241</td></tr><tr><td align="left" rowspan="1" colspan="1">Mature oocytes retrieved<break/>in stimulated cycles (n)</td><td align="left" rowspan="1" colspan="1">7.82&#x02009;&#x000b1;&#x02009;6.17</td><td align="left" rowspan="1" colspan="1">8.63&#x02009;&#x000b1;&#x02009;5.61</td><td align="left" rowspan="1" colspan="1">0.197</td></tr><tr><td align="left" rowspan="1" colspan="1">Oocyte maturation rate</td><td align="left" rowspan="1" colspan="1">75.9%</td><td align="left" rowspan="1" colspan="1">80.9%</td><td align="left" rowspan="1" colspan="1">0.517</td></tr><tr><td align="left" rowspan="1" colspan="1">Fertilized (2PN) oocyte (n)</td><td align="left" rowspan="1" colspan="1">5.07&#x02009;&#x000b1;&#x02009;4.16</td><td align="left" rowspan="1" colspan="1">6.65&#x02009;&#x000b1;&#x02009;4.61</td><td align="left" rowspan="1" colspan="1">0.043</td></tr><tr><td align="left" rowspan="1" colspan="1">Fertilization rate</td><td align="left" rowspan="1" colspan="1">48.7%</td><td align="left" rowspan="1" colspan="1">61.6%</td><td align="left" rowspan="1" colspan="1">0.098</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cleavage-stage embryo (n)</td><td align="left" rowspan="1" colspan="1">4.86&#x02009;&#x000b1;&#x02009;4.26</td><td align="left" rowspan="1" colspan="1">6.63&#x02009;&#x000b1;&#x02009;4.61</td><td align="left" rowspan="1" colspan="1">0.016</td></tr><tr><td align="left" rowspan="1" colspan="1">Cleaved embryo formation rate</td><td align="left" rowspan="1" colspan="1">95.3%</td><td align="left" rowspan="1" colspan="1">99.6%</td><td align="left" rowspan="1" colspan="1">0.276</td></tr><tr><td align="left" rowspan="1" colspan="1">Total morula-stage embryo (n)</td><td align="left" rowspan="1" colspan="1">4.00&#x02009;&#x000b1;&#x02009;4.51</td><td align="left" rowspan="1" colspan="1">6.05&#x02009;&#x000b1;&#x02009;5.14</td><td align="left" rowspan="1" colspan="1">0.024</td></tr><tr><td align="left" rowspan="1" colspan="1">Morula-stage embryo formation rate</td><td align="left" rowspan="1" colspan="1">78.0%</td><td align="left" rowspan="1" colspan="1">91.6%</td><td align="left" rowspan="1" colspan="1">0.076</td></tr><tr><td align="left" rowspan="1" colspan="1">Total blastocyst-stage embryo (n)</td><td align="left" rowspan="1" colspan="1">1.64&#x02009;&#x000b1;&#x02009;1.91</td><td align="left" rowspan="1" colspan="1">2.38&#x02009;&#x000b1;&#x02009;2.32</td><td align="left" rowspan="1" colspan="1">0.060</td></tr><tr><td align="left" rowspan="1" colspan="1">Blastocyst formation rate</td><td align="left" rowspan="1" colspan="1">32.3%</td><td align="left" rowspan="1" colspan="1">38.9%</td><td align="left" rowspan="1" colspan="1">0.180</td></tr><tr><td align="left" rowspan="1" colspan="1">Usable embryo (n)</td><td align="left" rowspan="1" colspan="1">1.30&#x02009;&#x000b1;&#x02009;1.33</td><td align="left" rowspan="1" colspan="1">1.85&#x02009;&#x000b1;&#x02009;1.56</td><td align="left" rowspan="1" colspan="1">0.075</td></tr><tr><td align="left" rowspan="1" colspan="1">Usable embryo rate</td><td align="left" rowspan="1" colspan="1">25.2%</td><td align="left" rowspan="1" colspan="1">27.2%</td><td align="left" rowspan="1" colspan="1">0.817</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p>Data are presented either as mean&#x02009;&#x000b1;&#x02009;standard deviation or as percentages.</p></fn><fn id="t005fn002"><p>Abbreviations: IVF, <italic toggle="yes">in vitro</italic> fertilization; BMI, body mass index; AMH, anti-M&#x000fc;llerian hormone.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="conclusions" id="sec014"><title>Discussion</title><p>Lipid metabolic pathways, including the TAG breakdown, FA oxidation, and cholesterol uptake pathways, are active within the COC. The lipid and FA compositions of the FF vary with the developmental stage of the ovarian follicle, reflecting differences in lipid function [<xref rid="pone.0324511.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0324511.ref027" ref-type="bibr">27</xref>]. Because oocytes have low glycolytic activity, they primarily depend on internal lipid storage within the COC and external sources such as FAs and amino acids from the FF for energy [<xref rid="pone.0324511.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0324511.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0324511.ref026" ref-type="bibr">26</xref>]. This metabolically quiescent state continues until the early CL stage due to limited glycolytic activity [<xref rid="pone.0324511.ref042" ref-type="bibr">42</xref>]. Recent proteomics and transcriptomics studies have highlighted the essential role of lipid metabolism in folliculogenesis and oocyte maturation [<xref rid="pone.0324511.ref042" ref-type="bibr">42</xref>&#x02013;<xref rid="pone.0324511.ref044" ref-type="bibr">44</xref>]. Lipid metabolism influences chromatin dynamics and gene expression, affecting both nuclear and cytoplasmic maturation of oocytes and early embryonic development [<xref rid="pone.0324511.ref043" ref-type="bibr">43</xref>]. As COH promotes the development of additional follicles and maturation of more oocytes, lipid metabolism becomes increasingly crucial.</p><p>Here, we report that neutral lipids, which are the primary sources of lipid metabolism, exhibited the most significant differences between the obese and non-obese groups. Consistent with other studies, the TAG levels were markedly higher in the obese group than in the non-obese group, indicating a significant positive correlation with the BMI [<xref rid="pone.0324511.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0324511.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0324511.ref025" ref-type="bibr">25</xref>,<xref rid="pone.0324511.ref026" ref-type="bibr">26</xref>,<xref rid="pone.0324511.ref034" ref-type="bibr">34</xref>,<xref rid="pone.0324511.ref035" ref-type="bibr">35</xref>]. Additionally, we observed significant differences in the numbers of fertilized oocytes, CL-stage embryos, and MO-stage embryos between the groups. This aligns with existing studies indicating that elevated triglyceride (TG) levels in the FF are associated with oocyte CL failure and reduced embryo viability [<xref rid="pone.0324511.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0324511.ref022" ref-type="bibr">22</xref>,<xref rid="pone.0324511.ref031" ref-type="bibr">31</xref>,<xref rid="pone.0324511.ref045" ref-type="bibr">45</xref>].</p><p>In addition to elevated TAG levels, our analysis revealed that the obese group exhibited higher DAG levels, suggesting a statistically significant positive correlation with the BMI. In contrast, the obese group exhibited lower MAG levels than the non-obese group.</p><p>Lipolysis in the COC involves the action of lipases, which are likely to be regulated during maturation. Lipolysis begins with the action of adipose TG lipase, which hydrolyzes TAG to DAG and FA. Subsequently, a hormone-sensitive lipase breaks down DAG into MAG, which is ultimately converted into FA and glycerol by MAG lipase [<xref rid="pone.0324511.ref046" ref-type="bibr">46</xref>]. Our results suggest that the initial steps of lipolysis in the FF are less effective in the obese group, as indicated by the accumulation of DAG, an intermediate metabolite, and reduced levels of MAG, the final metabolite of lipolysis. Although the mechanisms linking obesity and ineffective lipolysis within the COC are not well-established, a study on adipocytes showed decreased catecholamine-stimulated lipolysis and an antilipolytic effect of insulin in obesity [<xref rid="pone.0324511.ref047" ref-type="bibr">47</xref>].</p><p>Furthermore, incomplete lipolysis leads to the accumulation of DAG, a critical signaling molecule, during fertilization and early embryonic development. After sperm and oocyte fusion, DAG is generated by sperm-specific phospholipase C zeta hydrolyzing phosphatidylinositol 4,5-bisphosphate [<xref rid="pone.0324511.ref048" ref-type="bibr">48</xref>]. DAG then activates protein kinase C (PKC), which regulates meiosis resumption, cytoskeletal dynamics, and the mitogen-activated protein kinase pathway, which are essential for oocyte maturation, fertilization, and early embryonic development [<xref rid="pone.0324511.ref049" ref-type="bibr">49</xref>&#x02013;<xref rid="pone.0324511.ref051" ref-type="bibr">51</xref>].</p><p>However, research on mouse COC revealed that high DAG concentrations eventually reduce fertilization, as excessive DAG in phospholipase C zeta-injected eggs can trigger PKC-mediated Ca<sup>2+</sup> influx, leading to Ca<sup>2+</sup> overload and disrupted homeostasis [<xref rid="pone.0324511.ref051" ref-type="bibr">51</xref>]. Microinjection of DAG into oocytes also results in developmental arrest at the 4- to 68-cell stage [<xref rid="pone.0324511.ref052" ref-type="bibr">52</xref>]. Additionally, prolonged DAG activation in T cells downregulates PKC isoforms [<xref rid="pone.0324511.ref053" ref-type="bibr">53</xref>&#x02013;<xref rid="pone.0324511.ref055" ref-type="bibr">55</xref>]. Studies in human liver and muscle tissues have indicated that elevated DAG levels activate PKC, disrupt insulin signaling, and contribute to insulin resistance and lipotoxicity [<xref rid="pone.0324511.ref056" ref-type="bibr">56</xref>&#x02013;<xref rid="pone.0324511.ref058" ref-type="bibr">58</xref>]. Although no study has specifically examined the effects of DAG on human oocytes, our findings suggest that elevated DAG levels may contribute to poor fertilization and embryonic outcomes.</p><p>AC acts as the transportation site for FAs across the mitochondrial membrane and undergoes &#x003b2;-oxidation, which is a significant energy-producing process [<xref rid="pone.0324511.ref055" ref-type="bibr">55</xref>]. Given that oocytes and early embryos exhibit low glycolytic activity, &#x003b2;-oxidation is crucial during these stages. The accumulation of ACs in the obesity group indicates incomplete &#x003b2;-oxidation and, by extension, an inefficient FA oxidation process. This inefficiency can lead to decreased adenosine triphosphate levels, which may disrupt meiotic spindle formation and lead to failure of chromosomal segregation, maturation, and fertilization [<xref rid="pone.0324511.ref059" ref-type="bibr">59</xref>]. These disruptions are characterized by a lower number of fertilized oocytes and poor early embryological outcomes. Furthermore, long-chain ACs are correlated with gonadotropin-induced T levels, resulting in hormonal imbalances [<xref rid="pone.0324511.ref024" ref-type="bibr">24</xref>]. Additionally, a metabolomics study revealed that elevated plasma levels of medium- and long-chain ACs are associated with an increased risk of diabetic cardiomyopathy, which exacerbates myocardial lipotoxicity [<xref rid="pone.0324511.ref060" ref-type="bibr">60</xref>]. Thus, our detailed analysis of individual AC chains provides valuable insights, suggesting that the accumulation of ACs may be detrimental to embryological outcomes.</p><p>In this study, we utilized a large-scale untargeted lipidomic approach to comprehensively identify lipidomic profiles and analyze a diverse range of lipid classes and subtypes. A few human studies have explored the relationship between BMI, FF lipidomes, and embryological outcomes. Although the dynamics of lipid metabolism during oocyte maturation, fertilization, and early embryonic development in humans remain unclear, our findings highlight significant differences in the composition of follicular fluid lipids and their influence on embryological outcomes. However, this study has several limitations.</p><p>While we excluded patients with underlying metabolic diseases, we included three individuals with endometriosis and six with polycystic ovary syndrome, which may influence the local FF microenvironment. However, the number of patients with these conditions was small. Additionally, only metabolically healthy patients with polycystic ovary syndrome and those with mild endometriosis (lesions&#x02009;&#x02264;&#x02009;1.5&#x02009;cm) were included in our analysis. Few studies have suggested a relationship between FF lipid changes, age, and ovarian reserve [<xref rid="pone.0324511.ref061" ref-type="bibr">61</xref>,<xref rid="pone.0324511.ref062" ref-type="bibr">62</xref>]. However, the lack of significant differences in the mean AMH levels or age between the obese and non-obese groups suggests that age possibly had minimal impact on our findings. Since we focused on patients without hyperlipidemia, we only measured total serum cholesterol levels. Given that the composition of FF metabolites originates from the blood and COC, additional lipidomic analyses, including LDL, HDL, and TGs, would further enhance our understanding of how obesity affects the FF lipidome. The small sample size is another limitation, and it is challenging to determine whether the observed results are a cause or an effect. Consequently, studies with larger sample sizes are warranted to validate our findings, and further mechanistic studies are required to elucidate the underlying pathways. In addition, multicenter studies involving diverse populations are essential to confirm the generalizability of our findings across different clinical settings.</p></sec><sec sec-type="conclusions" id="sec015"><title>Conclusions</title><p>This is the first large-scale lipidomic study involving the FF to identify differences in metabolic profiles in the ovarian microenvironment associated with obesity in Korean women with infertility. We observed significant differences in the number of fertilized oocytes, CL-stage embryos, and MO-stage embryos, indicating altered embryonic development in the obese group. Analysis of the FF lipid composition provides valuable insights into the metabolic state and microenvironment of the COC. The accumulation of TAGs and DAGs, coupled with lower levels of MAGs and higher levels of ACs in the obese group, indicated inefficient lipid metabolism with insufficient energy production and potential lipotoxicity. This lipid imbalance may compromise early embryological outcomes in patients with obesity. Our results provide crucial insights into the importance of balanced lipid metabolism under conditions of increased energy demand during early embryonic development. This study provides a deeper understanding of the pathophysiology of lipid metabolism and obesity during early embryonic development. Mechanistic studies with larger sample sizes are needed to understand obesity-associated lipid metabolism and develop targeted interventions to improve fertility outcomes in women with obesity. Moreover, multicenter studies are necessary to enhance the external validity of our results and ensure their applicability to broader patient populations.</p></sec><sec id="sec016" sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="pone.0324511.s001" position="float" content-type="local-data"><label>S1 Table</label><caption><title>SRM condition of phospholipids in lipid droplet by LC-MS/MS.</title><p>SRM, selected reaction monitoring; LC, liquid chromatography; MS, mass spectrometry; LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; PC, phosphatidylcholine; PE, phosphatidylethanolamine</p><p>(DOCX)</p></caption><media xlink:href="pone.0324511.s001.docx"/></supplementary-material><supplementary-material id="pone.0324511.s002" position="float" content-type="local-data"><label>S2 Table</label><caption><title>SRM condition of neutral lipids in lipid droplet by LC-MS/MS.</title><p>SRM, selected reaction monitoring; LC, liquid chromatography; MS, mass spectrometry; MAG, monoacylglycerol; DAG, diacylglycerol; TAG, triacylglycerol.</p><p>(DOCX)</p></caption><media xlink:href="pone.0324511.s002.docx"/></supplementary-material><supplementary-material id="pone.0324511.s003" position="float" content-type="local-data"><label>S3 Table</label><caption><title>SRM condition of sphingolipid in lipid droplet by LC-MS/MS.</title><p>SRM, selected reaction monitoring; LC, liquid chromatography; MS, mass spectrometry; SM, sphingomyelin; CER, ceramide.</p><p>(DOCX)</p></caption><media xlink:href="pone.0324511.s003.docx"/></supplementary-material><supplementary-material id="pone.0324511.s004" position="float" content-type="local-data"><label>S4 Table</label><caption><title>SRM condition of sterol lipid in lipid droplet by LC-MS/MS.</title><p>SRM, selected reaction monitoring; LC, liquid chromatography; MS, mass spectrometry; CE, cholesteryl ester.</p><p>(DOCX)</p></caption><media xlink:href="pone.0324511.s004.docx"/></supplementary-material><supplementary-material id="pone.0324511.s005" position="float" content-type="local-data"><label>S5 Table</label><caption><title>SRM condition of carnitine in lipid droplet by LC-MS/MS.</title><p>SRM, selected reaction monitoring; LC, liquid chromatography; MS, mass spectrometry.</p><p>(DOCX)</p></caption><media xlink:href="pone.0324511.s005.docx"/></supplementary-material></sec></body><back><ack><p>None.</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>IVF</term><def><p><italic toggle="yes">In</italic> vitro fertilization</p></def></def-item><def-item><term>ICSI</term><def><p>Intracytoplasmic sperm injection</p></def></def-item><def-item><term>BMI</term><def><p>Body mass index</p></def></def-item><def-item><term>COH</term><def><p>Controlled ovarian hyperstimulation</p></def></def-item><def-item><term>COC</term><def><p>Cumulus&#x02013;oocyte complexes</p></def></def-item><def-item><term>FF</term><def><p>Follicular fluid</p></def></def-item><def-item><term>KSSO</term><def><p>Korean Society for the Study of Obesity</p></def></def-item><def-item><term>LC-MS</term><def><p>Liquid chromatography&#x02013;tandem mass spectrometry</p></def></def-item><def-item><term>hCG</term><def><p>Human chorionic gonadotropin</p></def></def-item><def-item><term>QC</term><def><p>Quality control</p></def></def-item><def-item><term>PKC</term><def><p>Protein kinase C</p></def></def-item><def-item><term>PCA</term><def><p>Principal component analysis</p></def></def-item><def-item><term>MAG</term><def><p>Monoacylglycerol</p></def></def-item><def-item><term>DAG</term><def><p>Diacylglycerol</p></def></def-item><def-item><term>TAG</term><def><p>Triacylglycerol</p></def></def-item><def-item><term>AC</term><def><p>Acylcarnitine</p></def></def-item><def-item><term>PC</term><def><p>Phosphatidylcholine</p></def></def-item><def-item><term>TG</term><def><p>Triglyceride</p></def></def-item><def-item><term>FA</term><def><p>Fatty acid</p></def></def-item><def-item><term>CL</term><def><p>Cleavage</p></def></def-item><def-item><term>MO</term><def><p>Morula</p></def></def-item><def-item><term>BL</term><def><p>Blastocyst.</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="pone.0324511.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>J</given-names></name>, <name><surname>Choo</surname><given-names>C-W</given-names></name>, <name><surname>Moon</surname><given-names>KY</given-names></name>, <name><surname>Lyu</surname><given-names>SW</given-names></name>, <name><surname>Kim</surname><given-names>H</given-names></name>, <name><surname>Lee</surname><given-names>JY</given-names></name>, <etal>et al</etal>. <article-title>Risk factors for infertility in Korean Women</article-title>. <source>J Korean Med Sci</source>. <year>2024</year>;<volume>39</volume>(<issue>10</issue>):e85. <comment>doi: </comment><pub-id pub-id-type="doi">10.3346/jkms.2024.39.e85</pub-id>
<pub-id pub-id-type="pmid">38501182</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref002"><label>2</label><mixed-citation publication-type="journal"><article-title>Obesity and reproduction: a committee opinion</article-title>. <source>Fertil Steril</source>. <year>2021</year>;<volume>116</volume>(<issue>5</issue>):<fpage>1266</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">34583840</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Garc&#x000ed;a-Ferreyra</surname><given-names>J</given-names></name>, <name><surname>Carpio</surname><given-names>J</given-names></name>, <name><surname>Zambrano</surname><given-names>M</given-names></name>, <name><surname>Valdivieso-Mej&#x000ed;a</surname><given-names>P</given-names></name>, <name><surname>Valdivieso-Rivera</surname><given-names>P</given-names></name>. <article-title>Overweight and obesity significantly reduce pregnancy, implantation, and live birth rates in women undergoing in vitro fertilization procedures</article-title>. <source>JBRA Assist Reprod</source>. <year>2021</year>;<volume>25</volume>(<issue>3</issue>):<fpage>394</fpage>&#x02013;<lpage>402</lpage>.<pub-id pub-id-type="pmid">33710838</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Wuytack</surname><given-names>F</given-names></name>, <name><surname>Devlieger</surname><given-names>R</given-names></name>, <name><surname>Ameye</surname><given-names>L</given-names></name>, <name><surname>Corcoran</surname><given-names>P</given-names></name>, <name><surname>Fitzgerald</surname><given-names>AP</given-names></name>, <name><surname>Ombelet</surname><given-names>W</given-names></name>. <article-title>Impact of female obesity and assisted reproduction on uncomplicated pregnancies and healthy births: a study of 428 336 births in Flanders</article-title>. <source>Hum Reprod</source>. <year>2023</year>;<volume>38</volume>(<issue>1</issue>):<fpage>156</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="pmid">36256863</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Rafael</surname><given-names>F</given-names></name>, <name><surname>Rodrigues</surname><given-names>M</given-names></name>, <name><surname>Bellver</surname><given-names>J</given-names></name>, <name><surname>Canelas-Pais</surname><given-names>M</given-names></name>, <name><surname>Garrido</surname><given-names>N</given-names></name>, <name><surname>Garcia-Velasco</surname><given-names>J</given-names></name>. <article-title>The combined effect of BMI and age on ART outcomes</article-title>. <source>Hum Reprod</source>. <year>2023</year>;<volume>38</volume>(<issue>5</issue>):<fpage>886</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">36928306</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Tang</surname><given-names>J</given-names></name>, <name><surname>Xu</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Ji</surname><given-names>X</given-names></name>, <name><surname>Qiu</surname><given-names>Q</given-names></name>, <name><surname>Mai</surname><given-names>Z</given-names></name>. <article-title>Association between metabolic healthy obesity and female infertility: the national health and nutrition examination survey, 2013-2020</article-title>. <source>BMC Public Health</source>. <year>2023</year>;<volume>23</volume>(<issue>1</issue>):<fpage>1524</fpage>.<pub-id pub-id-type="pmid">37563562</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Bellver</surname><given-names>J</given-names></name>, <name><surname>Brand&#x000e3;o</surname><given-names>P</given-names></name>, <name><surname>Alegre</surname><given-names>L</given-names></name>, <name><surname>Meseguer</surname><given-names>M</given-names></name>. <article-title>Blastocyst formation is similar in obese and normal weight women: a morphokinetic study</article-title>. <source>Hum Reprod</source>. <year>2021</year>;<volume>36</volume>(<issue>12</issue>):<fpage>3062</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">34601596</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Kidera</surname><given-names>N</given-names></name>, <name><surname>Ishikawa</surname><given-names>T</given-names></name>, <name><surname>Kawamura</surname><given-names>T</given-names></name>, <name><surname>Miyasaka</surname><given-names>N</given-names></name>. <article-title>Maternal body mass index is not associated with assisted reproductive technology outcomes</article-title>. <source>Sci Rep</source>. <year>2023</year>;<volume>13</volume>(<issue>1</issue>):<fpage>14817</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-023-41780-4</pub-id>
<pub-id pub-id-type="pmid">37684397</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Yong</surname><given-names>W</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <name><surname>Leng</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Wang</surname><given-names>H</given-names></name>. <article-title>Role of obesity in female reproduction</article-title>. <source>Int J Med Sci</source>. <year>2023</year>;<volume>20</volume>(<issue>3</issue>):<fpage>366</fpage>&#x02013;<lpage>75</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.7150/ijms.80189</pub-id>
<pub-id pub-id-type="pmid">36860674</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>S&#x000f8;rensen</surname><given-names>TIA</given-names></name>, <name><surname>Virtue</surname><given-names>S</given-names></name>, <name><surname>Vidal-Puig</surname><given-names>A</given-names></name>. <article-title>Obesity as a clinical and public health problem: is there a need for a new definition based on lipotoxicity effects?</article-title>. <source>Biochim Biophys Acta</source>. <year>2010</year>;<volume>1801</volume>(<issue>3</issue>):<fpage>400</fpage>&#x02013;<lpage>4</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.bbalip.2009.12.011</pub-id>
<pub-id pub-id-type="pmid">20045743</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>LL-Y</given-names></name>, <name><surname>Dunning</surname><given-names>KR</given-names></name>, <name><surname>Yang</surname><given-names>X</given-names></name>, <name><surname>Russell</surname><given-names>DL</given-names></name>, <name><surname>Lane</surname><given-names>M</given-names></name>, <name><surname>Norman</surname><given-names>RJ</given-names></name>, <etal>et al</etal>. <article-title>High-fat diet causes lipotoxicity responses in cumulus-oocyte complexes and decreased fertilization rates</article-title>. <source>Endocrinology</source>. <year>2010</year>;<volume>151</volume>(<issue>11</issue>):<fpage>5438</fpage>&#x02013;<lpage>45</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1210/en.2010-0551</pub-id>
<pub-id pub-id-type="pmid">20861227</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Si</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>N</given-names></name>, <name><surname>Wang</surname><given-names>M</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Niu</surname><given-names>Z</given-names></name>, <name><surname>Ding</surname><given-names>Z</given-names></name>. <article-title>TMT-based proteomic and bioinformatic analyses of human granulosa cells from obese and normal-weight female subjects</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2021</year>;<volume>19</volume>(<issue>1</issue>):<fpage>75</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12958-021-00760-x</pub-id>
<pub-id pub-id-type="pmid">34016141</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Dick</surname><given-names>KJ</given-names></name>, <name><surname>Nelson</surname><given-names>CP</given-names></name>, <name><surname>Tsaprouni</surname><given-names>L</given-names></name>, <name><surname>Sandling</surname><given-names>JK</given-names></name>, <name><surname>A&#x000ef;ssi</surname><given-names>D</given-names></name>, <name><surname>Wahl</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>DNA methylation and body-mass index: a genome-wide analysis</article-title>. <source>Lancet</source>. <year>2014</year>;<volume>383</volume>(<issue>9933</issue>):<fpage>1990</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(13)62674-4</pub-id>
<pub-id pub-id-type="pmid">24630777</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Crujeiras</surname><given-names>AB</given-names></name>, <name><surname>Casanueva</surname><given-names>FF</given-names></name>. <article-title>Obesity and the reproductive system disorders: epigenetics as a potential bridge</article-title>. <source>Hum Reprod Update</source>. <year>2015</year>;<volume>21</volume>(<issue>2</issue>):<fpage>249</fpage>&#x02013;<lpage>61</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/humupd/dmu060</pub-id>
<pub-id pub-id-type="pmid">25413685</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>T</given-names></name>, <name><surname>Qu</surname><given-names>J</given-names></name>, <name><surname>Tian</surname><given-names>M</given-names></name>, <name><surname>Yang</surname><given-names>R</given-names></name>, <name><surname>Song</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Lipid metabolic process involved in oocyte maturation during folliculogenesis</article-title>. <source>Front Cell Dev Biol</source>. <year>2022</year>;<volume>10</volume>:<fpage>806890</fpage>.<pub-id pub-id-type="pmid">35433675</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Ruebel</surname><given-names>M</given-names></name>, <name><surname>Shankar</surname><given-names>K</given-names></name>, <name><surname>Gaddy</surname><given-names>D</given-names></name>, <name><surname>Lindsey</surname><given-names>F</given-names></name>, <name><surname>Badger</surname><given-names>T</given-names></name>, <name><surname>Andres</surname><given-names>A</given-names></name>. <article-title>Maternal obesity is associated with ovarian inflammation and upregulation of early growth response factor 1</article-title>. <source>Am J Physiol Endocrinol Metab</source>. <year>2016</year>;<volume>311</volume>(<issue>1</issue>):E269-77. <comment>doi: </comment><pub-id pub-id-type="doi">10.1152/ajpendo.00524.2015</pub-id>
<pub-id pub-id-type="pmid">27279249</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Wyse</surname><given-names>BA</given-names></name>, <name><surname>Fuchs Weizman</surname><given-names>N</given-names></name>, <name><surname>Defer</surname><given-names>M</given-names></name>, <name><surname>Montbriand</surname><given-names>J</given-names></name>, <name><surname>Szaraz</surname><given-names>P</given-names></name>, <name><surname>Librach</surname><given-names>C</given-names></name>. <article-title>The follicular fluid adipocytokine milieu could serve as a prediction tool for fertility treatment outcomes</article-title>. <source>Reprod Biomed Online</source>. <year>2021</year>;<volume>43</volume>(<issue>4</issue>):<fpage>738</fpage>&#x02013;<lpage>46</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.rbmo.2021.07.001</pub-id>
<pub-id pub-id-type="pmid">34474976</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>T</given-names></name>, <name><surname>Kim</surname><given-names>Y</given-names></name>, <name><surname>Lucien</surname><given-names>F</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Enninga</surname><given-names>EAL</given-names></name>. <article-title>Decreased gremlin 1 expression in women with BMI &#x02265;35&#x02009;kg/m2 is mediated by interleukin 10 and interleukin 1&#x003b2; in the follicular fluid</article-title>. <source>F S Sci</source>. <year>2020</year>;<volume>1</volume>(<issue>1</issue>):<fpage>16</fpage>&#x02013;<lpage>26</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.xfss.2020.06.003</pub-id>
<pub-id pub-id-type="pmid">34296200</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Dumesic</surname><given-names>DA</given-names></name>, <name><surname>Meldrum</surname><given-names>DR</given-names></name>, <name><surname>Katz-Jaffe</surname><given-names>MG</given-names></name>, <name><surname>Krisher</surname><given-names>RL</given-names></name>, <name><surname>Schoolcraft</surname><given-names>WB</given-names></name>. <article-title>Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health</article-title>. <source>Fertil Steril</source>. <year>2015</year>;<volume>103</volume>(<issue>2</issue>):<fpage>303</fpage>&#x02013;<lpage>16</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.fertnstert.2014.11.015</pub-id>
<pub-id pub-id-type="pmid">25497448</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Da Broi</surname><given-names>MG</given-names></name>, <name><surname>Giorgi</surname><given-names>VSI</given-names></name>, <name><surname>Wang</surname><given-names>F</given-names></name>, <name><surname>Keefe</surname><given-names>DL</given-names></name>, <name><surname>Albertini</surname><given-names>D</given-names></name>, <name><surname>Navarro</surname><given-names>PA</given-names></name>. <article-title>Influence of follicular fluid and cumulus cells on oocyte quality: clinical implications</article-title>. <source>J Assist Reprod Genet</source>. <year>2018</year>;<volume>35</volume>(<issue>5</issue>):<fpage>735</fpage>&#x02013;<lpage>51</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10815-018-1143-3</pub-id>
<pub-id pub-id-type="pmid">29497954</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Viardot-Foucault</surname><given-names>V</given-names></name>, <name><surname>Zhou</surname><given-names>J</given-names></name>, <name><surname>Bi</surname><given-names>D</given-names></name>, <name><surname>Takinami</surname><given-names>Y</given-names></name>, <name><surname>Chan</surname><given-names>JKY</given-names></name>, <name><surname>Lee</surname><given-names>YH</given-names></name>. <article-title>Dehydroepiandrosterone supplementation and the impact of follicular fluid metabolome and cytokinome profiles in poor ovarian responders</article-title>. <source>J Ovarian Res</source>. <year>2023</year>;<volume>16</volume>(<issue>1</issue>):<fpage>107</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s13048-023-01166-6</pub-id>
<pub-id pub-id-type="pmid">37268990</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Dunning</surname><given-names>KR</given-names></name>, <name><surname>Russell</surname><given-names>DL</given-names></name>, <name><surname>Robker</surname><given-names>RL</given-names></name>. <article-title>Lipids and oocyte developmental competence: the role of fatty acids and &#x003b2;-oxidation</article-title>. <source>Reproduction</source>. <year>2014</year>;<volume>148</volume>(<issue>1</issue>):R15&#x02013;<lpage>27</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1530/REP-13-0251</pub-id>
<pub-id pub-id-type="pmid">24760880</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Perret</surname><given-names>BP</given-names></name>, <name><surname>Parinaud</surname><given-names>J</given-names></name>, <name><surname>Ribbes</surname><given-names>H</given-names></name>, <name><surname>Moatti</surname><given-names>JP</given-names></name>, <name><surname>Pontonnier</surname><given-names>G</given-names></name>, <name><surname>Chap</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Lipoprotein and phospholipid distribution in human follicular fluids</article-title>. <source>Fertil Steril</source>. <year>1985</year>;<volume>43</volume>(<issue>3</issue>):<fpage>405</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0015-0282(16)48440-2</pub-id>
<pub-id pub-id-type="pmid">3979578</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Gervais</surname><given-names>A</given-names></name>, <name><surname>Battista</surname><given-names>M-C</given-names></name>, <name><surname>Carranza-Mamane</surname><given-names>B</given-names></name>, <name><surname>Lavoie</surname><given-names>HB</given-names></name>, <name><surname>Baillargeon</surname><given-names>J-P</given-names></name>. <article-title>Follicular fluid concentrations of lipids and their metabolites are associated with intraovarian gonadotropin-stimulated androgen production in women undergoing in vitro fertilization</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2015</year>;<volume>100</volume>(<issue>5</issue>):<fpage>1845</fpage>&#x02013;<lpage>54</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1210/jc.2014-3649</pub-id>
<pub-id pub-id-type="pmid">25695883</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Batushansky</surname><given-names>A</given-names></name>, <name><surname>Zacharia</surname><given-names>A</given-names></name>, <name><surname>Shehadeh</surname><given-names>A</given-names></name>, <name><surname>Bruck-Haimson</surname><given-names>R</given-names></name>, <name><surname>Saidemberg</surname><given-names>D</given-names></name>, <name><surname>Kogan</surname><given-names>NM</given-names></name>, <etal>et al</etal>. <article-title>A shift in glycerolipid metabolism defines the follicular fluid of IVF patients with unexplained infertility</article-title>. <source>Biomolecules</source>. <year>2020</year>;<volume>10</volume>(<issue>8</issue>).</mixed-citation></ref><ref id="pone.0324511.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Zarezadeh</surname><given-names>R</given-names></name>, <name><surname>Nouri</surname><given-names>M</given-names></name>, <name><surname>Hamdi</surname><given-names>K</given-names></name>, <name><surname>Shaaker</surname><given-names>M</given-names></name>, <name><surname>Mehdizadeh</surname><given-names>A</given-names></name>, <name><surname>Darabi</surname><given-names>M</given-names></name>. <article-title>Fatty acids of follicular fluid phospholipids and triglycerides display distinct association with IVF outcomes</article-title>. <source>Reprod Biomed Online</source>. <year>2021</year>;<volume>42</volume>(<issue>2</issue>):<fpage>301</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.rbmo.2020.09.024</pub-id>
<pub-id pub-id-type="pmid">33279420</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Tilleman</surname><given-names>K</given-names></name>, <name><surname>Vlaeminck</surname><given-names>B</given-names></name>, <name><surname>Gervais</surname><given-names>R</given-names></name>, <name><surname>Chouinard</surname><given-names>PY</given-names></name>, <name><surname>De Sutter</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>The fatty acid composition in follicles is related to the developmental potential of oocytes up to the blastocyst stage: a single-centre cohort study</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2022</year>;<volume>20</volume>(<issue>1</issue>):<fpage>107</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12958-022-00974-7</pub-id>
<pub-id pub-id-type="pmid">35879714</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Ruiz-Sanz</surname><given-names>J-I</given-names></name>, <name><surname>P&#x000e9;rez-Ruiz</surname><given-names>I</given-names></name>, <name><surname>Meijide</surname><given-names>S</given-names></name>, <name><surname>Ferrando</surname><given-names>M</given-names></name>, <name><surname>Larreategui</surname><given-names>Z</given-names></name>, <name><surname>Ruiz-Larrea</surname><given-names>M-B</given-names></name>. <article-title>Lower follicular n-3 polyunsaturated fatty acid levels are associated with a better response to ovarian stimulation</article-title>. <source>J Assist Reprod Genet</source>. <year>2019</year>;<volume>36</volume>(<issue>3</issue>):<fpage>473</fpage>&#x02013;<lpage>82</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10815-018-1384-1</pub-id>
<pub-id pub-id-type="pmid">30547270</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Jungheim</surname><given-names>ES</given-names></name>, <name><surname>Macones</surname><given-names>GA</given-names></name>, <name><surname>Odem</surname><given-names>RR</given-names></name>, <name><surname>Patterson</surname><given-names>BW</given-names></name>, <name><surname>Lanzendorf</surname><given-names>SE</given-names></name>, <name><surname>Ratts</surname><given-names>VS</given-names></name>, <etal>et al</etal>. <article-title>Associations between free fatty acids, cumulus oocyte complex morphology and ovarian function during in vitro fertilization</article-title>. <source>Fertil Steril</source>. <year>2011</year>;<volume>95</volume>(<issue>6</issue>):<fpage>1970</fpage>&#x02013;<lpage>4</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.fertnstert.2011.01.154</pub-id>
<pub-id pub-id-type="pmid">21353671</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>V&#x000e1;rnagy</surname><given-names>A</given-names></name>, <name><surname>Bene</surname><given-names>J</given-names></name>, <name><surname>Sulyok</surname><given-names>E</given-names></name>, <name><surname>Kov&#x000e1;cs</surname><given-names>GL</given-names></name>, <name><surname>B&#x000f3;dis</surname><given-names>J</given-names></name>, <name><surname>Melegh</surname><given-names>B</given-names></name>. <article-title>Acylcarnitine esters profiling of serum and follicular fluid in patients undergoing in vitro fertilization</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2013</year>;<volume>11</volume>:<fpage>67</fpage>.<pub-id pub-id-type="pmid">23866102</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>J</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>S</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Feng</surname><given-names>R</given-names></name>, <name><surname>Huang</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Metabolic signatures in human follicular fluid identify lysophosphatidylcholine as a predictor of follicular development</article-title>. <source>Commun Biol</source>. <year>2022</year>;<volume>5</volume>(<issue>1</issue>):<fpage>763</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s42003-022-03710-4</pub-id>
<pub-id pub-id-type="pmid">35906399</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Hood</surname><given-names>RB</given-names></name>, <name><surname>Liang</surname><given-names>D</given-names></name>, <name><surname>Tan</surname><given-names>Y</given-names></name>, <name><surname>Ford</surname><given-names>JB</given-names></name>, <name><surname>Souter</surname><given-names>I</given-names></name>, <name><surname>Chavarro</surname><given-names>JE</given-names></name>, <etal>et al</etal>. <article-title>Serum and follicular fluid metabolome and markers of ovarian stimulation</article-title>. <source>Hum Reprod</source>. <year>2023</year>;<volume>38</volume>(<issue>11</issue>):<fpage>2196</fpage>&#x02013;<lpage>207</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/humrep/dead189</pub-id>
<pub-id pub-id-type="pmid">37740688</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Song</surname><given-names>J</given-names></name>, <name><surname>Xiang</surname><given-names>S</given-names></name>, <name><surname>Pang</surname><given-names>C</given-names></name>, <name><surname>Guo</surname><given-names>J</given-names></name>, <name><surname>Sun</surname><given-names>Z</given-names></name>. <article-title>Metabolomic alternations of follicular fluid of obese women undergoing in-vitro fertilization treatment</article-title>. <source>Sci Rep</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>5968</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-020-62975-z</pub-id>
<pub-id pub-id-type="pmid">32249791</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Valckx</surname><given-names>SD</given-names></name>, <name><surname>De Pauw</surname><given-names>I</given-names></name>, <name><surname>De Neubourg</surname><given-names>D</given-names></name>, <name><surname>Inion</surname><given-names>I</given-names></name>, <name><surname>Berth</surname><given-names>M</given-names></name>, <name><surname>Fransen</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>BMI-related metabolic composition of the follicular fluid of women undergoing assisted reproductive treatment and the consequences for oocyte and embryo quality</article-title>. <source>Hum Reprod</source>. <year>2012</year>;<volume>27</volume>(<issue>12</issue>):<fpage>3531</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">23019302</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Valckx</surname><given-names>SDM</given-names></name>, <name><surname>Arias-Alvarez</surname><given-names>M</given-names></name>, <name><surname>De Pauw</surname><given-names>I</given-names></name>, <name><surname>Fievez</surname><given-names>V</given-names></name>, <name><surname>Vlaeminck</surname><given-names>B</given-names></name>, <name><surname>Fransen</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Fatty acid composition of the follicular fluid of normal weight, overweight and obese women undergoing assisted reproductive treatment: a descriptive cross-sectional study</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2014</year>;<volume>12</volume>:<fpage>13</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1477-7827-12-13</pub-id>
<pub-id pub-id-type="pmid">24498875</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>de Lima</surname><given-names>CB</given-names></name>, <name><surname>Barbosa</surname><given-names>GZ</given-names></name>, <name><surname>Ispada</surname><given-names>J</given-names></name>, <name><surname>Dos Santos</surname><given-names>EC</given-names></name>, <name><surname>Milazzotto</surname><given-names>MP</given-names></name>. <article-title>Lipid availability during in vitro maturation alters oocyte lipid content and blastocyst development and metabolism</article-title>. <source>Reprod Domest Anim</source>. <year>2023</year>;<volume>58</volume>(<issue>7</issue>):<fpage>920</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/rda.14367</pub-id>
<pub-id pub-id-type="pmid">37120750</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Pawlak</surname><given-names>P</given-names></name>, <name><surname>Malyszka</surname><given-names>N</given-names></name>, <name><surname>Szczerbal</surname><given-names>I</given-names></name>, <name><surname>Kolodziejski</surname><given-names>P</given-names></name>. <article-title>Fatty acid induced lipolysis influences embryo development, gene expression and lipid droplet formation in the porcine cumulus cells&#x02020;</article-title>. <source>Biol Reprod</source>. <year>2020</year>;<volume>103</volume>(<issue>1</issue>):<fpage>36</fpage>&#x02013;<lpage>48</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/biolre/ioaa045</pub-id>
<pub-id pub-id-type="pmid">32318713</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Ohata</surname><given-names>K</given-names></name>, <name><surname>Ezoe</surname><given-names>K</given-names></name>, <name><surname>Miki</surname><given-names>T</given-names></name>, <name><surname>Kouraba</surname><given-names>S</given-names></name>, <name><surname>Fujiwara</surname><given-names>N</given-names></name>, <name><surname>Yabuuchi</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Effects of fatty acid supplementation during vitrification and warming on the developmental competence of mouse, bovine and human oocytes and embryos</article-title>. <source>Reprod Biomed Online</source>. <year>2021</year>;<volume>43</volume>(<issue>1</issue>):<fpage>14</fpage>&#x02013;<lpage>25</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.rbmo.2021.03.022</pub-id>
<pub-id pub-id-type="pmid">34049810</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Haam</surname><given-names>J-H</given-names></name>, <name><surname>Kim</surname><given-names>BT</given-names></name>, <name><surname>Kim</surname><given-names>EM</given-names></name>, <name><surname>Kwon</surname><given-names>H</given-names></name>, <name><surname>Kang</surname><given-names>J-H</given-names></name>, <name><surname>Park</surname><given-names>JH</given-names></name>, <etal>et al</etal>. <article-title>Diagnosis of obesity: 2022 update of clinical practice guidelines for obesity by the Korean society for the study of obesity</article-title>. <source>J Obes Metab Syndr</source>. <year>2023</year>;<volume>32</volume>(<issue>2</issue>):<fpage>121</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.7570/jomes23031</pub-id>
<pub-id pub-id-type="pmid">37386771</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Matyash</surname><given-names>V</given-names></name>, <name><surname>Liebisch</surname><given-names>G</given-names></name>, <name><surname>Kurzchalia</surname><given-names>TV</given-names></name>, <name><surname>Shevchenko</surname><given-names>A</given-names></name>, <name><surname>Schwudke</surname><given-names>D</given-names></name>. <article-title>Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics</article-title>. <source>J Lipid Res</source>. <year>2008</year>;<volume>49</volume>(<issue>5</issue>):<fpage>1137</fpage>&#x02013;<lpage>46</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1194/jlr.D700041-JLR200</pub-id>
<pub-id pub-id-type="pmid">18281723</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Want</surname><given-names>EJ</given-names></name>, <name><surname>Wilson</surname><given-names>ID</given-names></name>, <name><surname>Gika</surname><given-names>H</given-names></name>, <name><surname>Theodoridis</surname><given-names>G</given-names></name>, <name><surname>Plumb</surname><given-names>RS</given-names></name>, <name><surname>Shockcor</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Global metabolic profiling procedures for urine using UPLC-MS</article-title>. <source>Nat Protoc</source>. <year>2010</year>;<volume>5</volume>(<issue>6</issue>):<fpage>1005</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">20448546</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>R</given-names></name>, <name><surname>Jiang</surname><given-names>X</given-names></name>, <name><surname>Hameed</surname><given-names>U</given-names></name>, <name><surname>Shi</surname><given-names>Q</given-names></name>. <article-title>Role of lipid metabolism and signaling in mammalian oocyte maturation, quality, and acquisition of competence</article-title>. <source>Front Cell Dev Biol</source>. <year>2021</year>;<volume>9</volume>:<fpage>639704</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fcell.2021.639704</pub-id>
<pub-id pub-id-type="pmid">33748128</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>W</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Sturmey</surname><given-names>R</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>. <article-title>Dynamic metabolism during early mammalian embryogenesis</article-title>. <source>Development</source>. <year>2023</year>;<volume>150</volume>(<issue>20</issue>):dev202148. <comment>doi: </comment><pub-id pub-id-type="doi">10.1242/dev.202148</pub-id>
<pub-id pub-id-type="pmid">37877936</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Zhao</surname><given-names>J</given-names></name>, <name><surname>Lam</surname><given-names>SM</given-names></name>, <name><surname>Chen</surname><given-names>L</given-names></name>, <name><surname>Gao</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>W</given-names></name>, <etal>et al</etal>. <article-title>Low-input lipidomics reveals lipid metabolism remodelling during early mammalian embryo development</article-title>. <source>Nat Cell Biol</source>. <year>2024</year>;<volume>26</volume>(<issue>2</issue>):<fpage>278</fpage>&#x02013;<lpage>93</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41556-023-01341-3</pub-id>
<pub-id pub-id-type="pmid">38302721</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Wallace</surname><given-names>M</given-names></name>, <name><surname>Cottell</surname><given-names>E</given-names></name>, <name><surname>Gibney</surname><given-names>MJ</given-names></name>, <name><surname>McAuliffe</surname><given-names>FM</given-names></name>, <name><surname>Wingfield</surname><given-names>M</given-names></name>, <name><surname>Brennan</surname><given-names>L</given-names></name>. <article-title>An investigation into the relationship between the metabolic profile of follicular fluid, oocyte developmental potential, and implantation outcome</article-title>. <source>Fertil Steril</source>. <year>2012</year>;<volume>97</volume>(<issue>5</issue>):<fpage>1078</fpage>&#x02013;<lpage>84.e1-8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.fertnstert.2012.01.122</pub-id>
<pub-id pub-id-type="pmid">22365382</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Hofer</surname><given-names>P</given-names></name>, <name><surname>Taschler</surname><given-names>U</given-names></name>, <name><surname>Schreiber</surname><given-names>R</given-names></name>, <name><surname>Kotzbeck</surname><given-names>P</given-names></name>, <name><surname>Schoiswohl</surname><given-names>G</given-names></name>. <article-title>The lipolysome-a highly complex and dynamic protein network orchestrating cytoplasmic triacylglycerol degradation</article-title>. <source>Metabolites</source>. <year>2020</year>;<volume>10</volume>(<issue>4</issue>).</mixed-citation></ref><ref id="pone.0324511.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Duncan</surname><given-names>RE</given-names></name>, <name><surname>Ahmadian</surname><given-names>M</given-names></name>, <name><surname>Jaworski</surname><given-names>K</given-names></name>, <name><surname>Sarkadi-Nagy</surname><given-names>E</given-names></name>, <name><surname>Sul</surname><given-names>HS</given-names></name>. <article-title>Regulation of lipolysis in adipocytes</article-title>. <source>Annu Rev Nutr</source>. <year>2007</year>;<volume>27</volume>:<fpage>79</fpage>&#x02013;<lpage>101</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1146/annurev.nutr.27.061406.093734</pub-id>
<pub-id pub-id-type="pmid">17313320</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Anifandis</surname><given-names>G</given-names></name>, <name><surname>Michopoulos</surname><given-names>A</given-names></name>, <name><surname>Daponte</surname><given-names>A</given-names></name>, <name><surname>Chatzimeletiou</surname><given-names>K</given-names></name>, <name><surname>Simopoulou</surname><given-names>M</given-names></name>, <name><surname>Messini</surname><given-names>CI</given-names></name>, <etal>et al</etal>. <article-title>Artificial oocyte activation: physiological, pathophysiological and ethical aspects</article-title>. <source>Syst Biol Reprod Med</source>. <year>2019</year>;<volume>65</volume>(<issue>1</issue>):<fpage>3</fpage>&#x02013;<lpage>11</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/19396368.2018.1516000</pub-id>
<pub-id pub-id-type="pmid">30207496</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Kalive</surname><given-names>M</given-names></name>, <name><surname>Faust</surname><given-names>JJ</given-names></name>, <name><surname>Koeneman</surname><given-names>BA</given-names></name>, <name><surname>Capco</surname><given-names>DG</given-names></name>. <article-title>Involvement of the PKC family in regulation of early development</article-title>. <source>Mol Reprod Dev</source>. <year>2010</year>;<volume>77</volume>(<issue>2</issue>):<fpage>95</fpage>&#x02013;<lpage>104</lpage>.<pub-id pub-id-type="pmid">19777543</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Yi</surname><given-names>Z-Y</given-names></name>, <name><surname>Liang</surname><given-names>Q-X</given-names></name>, <name><surname>Meng</surname><given-names>T-G</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Dong</surname><given-names>M-Z</given-names></name>, <name><surname>Hou</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>PKC&#x003b2;1 regulates meiotic cell cycle in mouse oocyte</article-title>. <source>Cell Cycle</source>. <year>2019</year>;<volume>18</volume>(<issue>4</issue>):<fpage>395</fpage>&#x02013;<lpage>412</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/15384101.2018.1564492</pub-id>
<pub-id pub-id-type="pmid">30730241</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>Y</given-names></name>, <name><surname>Halet</surname><given-names>G</given-names></name>, <name><surname>Lai</surname><given-names>FA</given-names></name>, <name><surname>Swann</surname><given-names>K</given-names></name>. <article-title>Regulation of diacylglycerol production and protein kinase C stimulation during sperm- and PLCzeta-mediated mouse egg activation</article-title>. <source>Biol Cell</source>. <year>2008</year>;<volume>100</volume>(<issue>11</issue>):<fpage>633</fpage>&#x02013;<lpage>43</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1042/BC20080033</pub-id>
<pub-id pub-id-type="pmid">18471090</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Nair</surname><given-names>R</given-names></name>, <name><surname>Manikkath</surname><given-names>J</given-names></name>, <name><surname>Hegde</surname><given-names>AR</given-names></name>, <name><surname>Mutalik</surname><given-names>S</given-names></name>, <name><surname>Kalthur</surname><given-names>G</given-names></name>, <name><surname>Adiga</surname><given-names>SK</given-names></name>. <article-title>Liposome-encapsulated diacyl glycerol and inositol triphosphate-induced delayed oocyte activation and poor development of parthenotes</article-title>. <source>J Turk Ger Gynecol Assoc</source>. <year>2017</year>;<volume>18</volume>(<issue>3</issue>):<fpage>102</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4274/jtgga.2017.0014</pub-id>
<pub-id pub-id-type="pmid">28890423</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Lum</surname><given-names>MA</given-names></name>, <name><surname>Barger</surname><given-names>CJ</given-names></name>, <name><surname>Hsu</surname><given-names>AH</given-names></name>, <name><surname>Leontieva</surname><given-names>OV</given-names></name>, <name><surname>Black</surname><given-names>AR</given-names></name>, <name><surname>Black</surname><given-names>JD</given-names></name>. <article-title>Protein Kinase C&#x003b1; (PKC&#x003b1;) is resistant to long term desensitization/down-regulation by prolonged diacylglycerol stimulation</article-title>. <source>J Biol Chem</source>. <year>2016</year>;<volume>291</volume>(<issue>12</issue>):<fpage>6331</fpage>&#x02013;<lpage>46</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1074/jbc.M115.696211</pub-id>
<pub-id pub-id-type="pmid">26769967</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Kiley</surname><given-names>SC</given-names></name>, <name><surname>Parker</surname><given-names>PJ</given-names></name>, <name><surname>Fabbro</surname><given-names>D</given-names></name>, <name><surname>Jaken</surname><given-names>S</given-names></name>. <article-title>Differential regulation of protein kinase C isozymes by thyrotropin-releasing hormone in GH4C1 cells</article-title>. <source>J Biol Chem</source>. <year>1991</year>;<volume>266</volume>(<issue>35</issue>):<fpage>23761</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0021-9258(18)54348-9</pub-id>
<pub-id pub-id-type="pmid">1748652</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Olivier</surname><given-names>AR</given-names></name>, <name><surname>Parker</surname><given-names>PJ</given-names></name>. <article-title>Bombesin, platelet-derived growth factor, and diacylglycerol induce selective membrane association and down-regulation of protein kinase C isotypes in Swiss 3T3 cells</article-title>. <source>J Biol Chem</source>. <year>1994</year>;<volume>269</volume>(<issue>4</issue>):<fpage>2758</fpage>&#x02013;<lpage>63</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0021-9258(17)42008-4</pub-id>
<pub-id pub-id-type="pmid">8300608</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Erion</surname><given-names>DM</given-names></name>, <name><surname>Shulman</surname><given-names>GI</given-names></name>. <article-title>Diacylglycerol-mediated insulin resistance</article-title>. <source>Nat Med</source>. <year>2010</year>;<volume>16</volume>(<issue>4</issue>):<fpage>400</fpage>&#x02013;<lpage>2</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nm0410-400</pub-id>
<pub-id pub-id-type="pmid">20376053</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Jani</surname><given-names>S</given-names></name>, <name><surname>Da Eira</surname><given-names>D</given-names></name>, <name><surname>Hadday</surname><given-names>I</given-names></name>, <name><surname>Bikopoulos</surname><given-names>G</given-names></name>, <name><surname>Mohasses</surname><given-names>A</given-names></name>, <name><surname>de Pinho</surname><given-names>RA</given-names></name>, <etal>et al</etal>. <article-title>Distinct mechanisms involving diacylglycerol, ceramides, and inflammation underlie insulin resistance in oxidative and glycolytic muscles from high fat-fed rats</article-title>. <source>Sci Rep</source>. <year>2021</year>;<volume>11</volume>(<issue>1</issue>):<fpage>19160</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-021-98819-7</pub-id>
<pub-id pub-id-type="pmid">34580412</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Petersen</surname><given-names>MC</given-names></name>, <name><surname>Shulman</surname><given-names>GI</given-names></name>. <article-title>Roles of diacylglycerols and ceramides in hepatic insulin resistance</article-title>. <source>Trends Pharmacol Sci</source>. <year>2017</year>;<volume>38</volume>(<issue>7</issue>):<fpage>649</fpage>&#x02013;<lpage>65</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.tips.2017.04.004</pub-id>
<pub-id pub-id-type="pmid">28551355</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Pei</surname><given-names>Z</given-names></name>, <name><surname>Deng</surname><given-names>K</given-names></name>, <name><surname>Xu</surname><given-names>C</given-names></name>, <name><surname>Zhang</surname><given-names>S</given-names></name>. <article-title>The molecular regulatory mechanisms of meiotic arrest and resumption in oocyte development and maturation</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2023</year>;<volume>21</volume>(<issue>1</issue>):<fpage>90</fpage>.<pub-id pub-id-type="pmid">37784186</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Zheng</surname><given-names>D-M</given-names></name>, <name><surname>An</surname><given-names>Z-N</given-names></name>, <name><surname>Ge</surname><given-names>M-H</given-names></name>, <name><surname>Wei</surname><given-names>D-Z</given-names></name>, <name><surname>Jiang</surname><given-names>D-W</given-names></name>, <name><surname>Xing</surname><given-names>X-J</given-names></name>, <etal>et al</etal>. <article-title>Medium &#x00026; long-chain acylcarnitine&#x02019;s relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study</article-title>. <source>Lipids Health Dis</source>. <year>2021</year>;<volume>20</volume>(<issue>1</issue>):<fpage>151</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12944-021-01576-9</pub-id>
<pub-id pub-id-type="pmid">34727932</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Liang</surname><given-names>C</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Qi</surname><given-names>C</given-names></name>, <name><surname>Hu</surname><given-names>H</given-names></name>, <name><surname>Zhang</surname><given-names>Q</given-names></name>, <name><surname>Zhu</surname><given-names>X</given-names></name>, <etal>et al</etal>. <article-title>UHPLC-MS-MS analysis of oxylipins metabolomics components of follicular fluid in infertile individuals with diminished ovarian reserve</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2021</year>;<volume>19</volume>(<issue>1</issue>):<fpage>143</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12958-021-00825-x</pub-id>
<pub-id pub-id-type="pmid">34521427</pub-id>
</mixed-citation></ref><ref id="pone.0324511.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Tilleman</surname><given-names>K</given-names></name>, <name><surname>Vlaeminck</surname><given-names>B</given-names></name>, <name><surname>Gervais</surname><given-names>R</given-names></name>, <name><surname>Chouinard</surname><given-names>PY</given-names></name>, <name><surname>De Sutter</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>The fatty acid composition in follicles is related to the developmental potential of oocytes up to the blastocyst stage: a single-centre cohort study</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2022</year>;<volume>20</volume>(<issue>1</issue>):<fpage>107</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12958-022-00974-7</pub-id>
<pub-id pub-id-type="pmid">35879714</pub-id>
</mixed-citation></ref></ref-list></back></article>